subject: CHEBI:8081

subject_name: Phentolamine

object_name: type 2 diabetes mellitus


subject: CHEBI:8081

object_name: Insulin resistance

tested_intervention: yes


subject: CHEBI:32696

object_name: diabetes mellitus

tested_intervention: unsure


subject: UNII:820NH671E6

subject_name: Prexasertib

object_name: small cell lung carcinoma


subject: PUBCHEM.COMPOUND:126843196

subject_name: Recombinant insulin Human


subject: UMLS:C1446598

subject_name: Recombinant human regular insulin


subject: CHEBI:6942

subject_name: Minoxidil

object_name: Complication of perfusion


subject: CHEBI:6942

object_name: inherited disease susceptibility


subject: CHEBI:51254

subject_name: AMOXICILLIN

object_name: streptococcal sore throat


subject: PUBCHEM.COMPOUND:2171


subject: CHEBI:2676

subject_name: Amoxicillin


subject: CHEBI:50730

subject_name: Montelukast

object_name: Chronic otitis media with effusion (disorder)


subject: CHEBI:50730

object_name: Glue ear


subject: CHEBI:50730

object_name: conductive hearing loss disorder


subject: UMLS:C2742210

object_name: Stage IV Primary Peritoneal Cancer AJCC v8


subject: UMLS:C2742210

object_name: Stage IV Primary Peritoneal Cancer AJCC v7


subject: UMLS:C2742210

object_name: Recurrent Primary Peritoneal Carcinoma


subject: UMLS:C2742210

object_name: Stage IV Fallopian Tube Cancer AJCC v6 and v7


subject: UMLS:C2742210

object_name: Stage IV Fallopian Tube Cancer AJCC v8


subject: UMLS:C2742210

object_name: Recurrent Fallopian Tube Carcinoma


subject: UMLS:C2348288

subject_name: Dietary Zinc

object_name: cardiovascular disorder


subject: CHEBI:29105

subject_name: Velmanase alfa


subject: CHEBI:27363

subject_name: Zinc


subject: UMLS:C3541396

subject_name: Zinc Supplements


subject: UMLS:C3714650

subject_name: Zinc Drug Class


subject: CHEBI:32660

subject_name: asparaginase

object_name: Adult B Acute Lymphoblastic Leukemia with t(9;22)(q34.1;q11.2); BCR-ABL1


subject: CHEBI:4911

subject_name: Etoposide

object_name: Childhood B Acute Lymphoblastic Leukemia with t(9;22)(q34.1;q11.2); BCR-ABL1


subject: CHEBI:17650

subject_name: Hydrocortisone


subject: CHEBI:17650


subject: CHEBI:5864

subject_name: Ifosfamide


subject: CHEBI:5864


subject: CHEBI:6888

subject_name: Methylprednisolone


subject: UNII:7D96IR0PPM

subject_name: Pegaspargase


subject: UNII:7D96IR0PPM


subject: PUBCHEM.COMPOUND:56841986

subject_name: Plasmalyte A

object_name: Hypotension during surgery


subject: UMLS:C3653500

subject_name: Direct Factor Xa Inhibitors

object_name: Traumatic intracranial hemorrhage


subject: CHEBI:44915

subject_name: Propofol

object_name: Limb fracture


subject: UMLS:C2222706

subject_name: sodium ferric gluconate complex in sucrose

object_name: iron deficiency anemia


subject: UMLS:C2222706

object_name: chronic kidney disease


subject: UMLS:C2222706

object_name: Chronic uremia


subject: CHEBI:32599

object_name: hypertension, pregnancy-induced


subject: CHEBI:32599

object_name: hypertension chronic


subject: CHEBI:32599

object_name: Pre-eclampsia added to pre-existing hypertension


subject: CHEBI:167638

subject_name: Labetalol


subject: CHEBI:167638


subject: UMLS:C5239084

object_name: prostate carcinoma


subject: UMLS:C5239084

object_name: prostate cancer


subject: PUBCHEM.COMPOUND:135565596

subject_name: Copanlisib

object_name: marginal zone lymphoma


subject: PUBCHEM.COMPOUND:135565596

object_name: MALT lymphoma


subject: CHEBI:173077


subject: CHEBI:173077


subject: CHEBI:71956

subject_name: retaspimycin hydrochloride

object_name: HER2 positive breast carcinoma


subject: CHEBI:71956

object_name: Carcinoma breast stage IV


subject: CHEBI:93755


subject: UMLS:C1708447

subject_name: IPI 504


subject: UMLS:C1708447


subject: PR:000015526

subject_name: transcription factor Spi-C

object_name: dental caries


subject: PR:000015526

object_name: Dental Caries, CTCAE


subject: UMLS:C0033374

subject_name: Prolactin-Releasing Hormone


subject: UMLS:C0033374


subject: PUBCHEM.COMPOUND:3199

subject_name: ecteinascidin 743

object_name: unspecified childhood solid tumor, protocol specific


subject: UMLS:C0388976

subject_name: Ecteinascidin 743


subject: PUBCHEM.COMPOUND:49865963

subject_name: TRABECTEDIN


subject: CHEBI:229236

subject_name: Fezolinetant

object_name: vasomotor symptom


subject: CHEBI:27812

subject_name: Methylselenocysteine

object_name: multiple sclerosis


subject: UMLS:C0770246

subject_name: PROTEIN SUPPLEMENTS

object_name: Protein Deficiency


subject: CHEBI:141969

subject_name: Tipifarnib

object_name: thyroid tumor


subject: CHEBI:141969

object_name: thyroid gland carcinoma


subject: CHEBI:141969

object_name: thyroid cancer


subject: PUBCHEM.COMPOUND:148193

subject_name: Tonapofylline


subject: PUBCHEM.COMPOUND:148193


subject: PUBCHEM.COMPOUND:148193


subject: CHEBI:5523

subject_name: Goserelin

object_name: Menopausal Symptom


subject: UMLS:C0149473

subject_name: Zoladex


subject: UMLS:C2348849

subject_name: ALVAC-MART-1 Vaccine

object_name: melanoma


subject: CHEBI:65415

subject_name: Antroquinonol

object_name: hepatitis B


subject: CHEBI:45783

subject_name: Imatinib

object_name: Brain Stem Glioblastoma


subject: CHEBI:45783

object_name: glioma susceptibility 1


subject: CHEBI:45783

object_name: Childhood Astrocytoma


subject: CHEBI:45783

object_name: astrocytic tumor


subject: CHEBI:45783

object_name: astrocytoma


subject: PUBCHEM.COMPOUND:5281767

subject_name: CURCUMIN

object_name: Memory observations


subject: UNII:X6SH5T8H76

object_name: T-cell childhood lymphoblastic lymphoma


subject: UNII:X6SH5T8H76

object_name: Adult T Lymphoblastic Lymphoma


subject: UNII:X6SH5T8H76

object_name: T-lymphoblastic lymphoma


subject: UNII:X6SH5T8H76

object_name: Refractory T Acute Lymphoblastic Leukemia


subject: UNII:X6SH5T8H76

object_name: Refractory T Lymphoblastic Lymphoma


subject: UNII:X6SH5T8H76

object_name: Recurrent Childhood T Acute Lymphoblastic Leukemia


subject: UNII:X6SH5T8H76

object_name: Recurrent T Acute Lymphoblastic Leukemia


subject: CHEBI:66910

subject_name: Axitinib

object_name: thyroid tumor


subject: UMLS:C0962969

subject_name: RAD 001


subject: UMLS:C0962969

object_name: thyroid gland carcinoma


subject: UMLS:C0962969

object_name: thyroid cancer


subject: MESH:D000451

subject_name: Mineralocorticoid Receptor Antagonists

object_name: hypertension


subject: MESH:D000451

object_name: Hypertension, CTCAE


subject: MESH:D000451

object_name: hyperaldosteronism


subject: UMLS:C1579268


subject: UMLS:C1579268


subject: UMLS:C1579268


subject: CHEBI:73611

subject_name: Met-Gly

object_name: impotence


subject: CHEBI:73611

object_name: Erectile Dysfunction, CTCAE


subject: CHEBI:73611

object_name: Erectile dysfunction


subject: CHEBI:73611

object_name: Testosterone deficiency


subject: CHEBI:73611

object_name: Testosterone Deficiency, CTCAE


subject: CHEBI:25107

subject_name: magnesium atom


subject: CHEBI:25107


subject: CHEBI:25107


subject: CHEBI:25107


subject: CHEBI:25107


subject: PR:000004501

subject_name: attractin


subject: PR:000004501


subject: PR:000004501


subject: PR:000004501


subject: PR:000004501


subject: UMLS:C0487173

subject_name: Mg antigen


subject: UMLS:C0487173


subject: UMLS:C0487173


subject: UMLS:C0487173


subject: UMLS:C0487173


subject: UMLS:C5706459

subject_name: CDK7 Inhibitor Q901

object_name: Advanced cancer


subject: UMLS:C5706459

object_name: Disseminated Malignant Neoplasm


subject: UMLS:C5706459

object_name: Embolism, Tumor


subject: UMLS:C5706459

object_name: Neoplasm Metastasis


subject: PUBCHEM.COMPOUND:131769963

subject_name: Digoxigenin monodigitoxoside

object_name: hepatobiliary disorder


subject: PUBCHEM.COMPOUND:131769963

object_name: liver disorder


subject: UNII:5XYK65KIGD


subject: UNII:5XYK65KIGD


subject: CHEBI:50924

subject_name: Sorafenib


subject: CHEBI:50924


subject: CHEBI:57694

object_name: head and neck squamous cell carcinoma


subject: CHEBI:16243

subject_name: Quercetin


subject: CHEBI:50847

subject_name: immunological adjuvant


subject: PUBCHEM.COMPOUND:135512673

subject_name: Rifampicin

object_name: Infection


subject: PUBCHEM.COMPOUND:135512673

object_name: infectious disease


subject: PUBCHEM.COMPOUND:135512673

object_name: Adverse Event Associated with Infection


subject: HMDB:HMDB0015179

subject_name: Rifampin


subject: HMDB:HMDB0015179


subject: HMDB:HMDB0015179


subject: UMLS:C5417989

subject_name: EP4 Antagonist INV-1120

object_name: Adult Solid Neoplasm


subject: UMLS:C5417989

object_name: Childhood Solid Neoplasm


subject: UMLS:C5417989

object_name: Solid Neoplasm


subject: UMLS:C5417989

object_name: unspecified adult solid tumor, protocol specific


subject: UMLS:C5417989

object_name: Solid carcinoma


subject: UMLS:C5417989


subject: UMLS:C5417989


subject: UMLS:C5417989

object_name: cancer


subject: UMLS:C5417989

object_name: neoplasm


subject: UNII:DPT0O3T46P

subject_name: Pembrolizumab


subject: CHEBI:8093

subject_name: Phenylephrine

object_name: vasomotor rhinitis


subject: GTOPDB:2479

subject_name: HCl

object_name: Atopic rhinitis


subject: GTOPDB:2479

object_name: Hay fever


subject: GTOPDB:2479


subject: UMLS:C1512523

subject_name: hydrochloride


subject: UMLS:C1512523


subject: UMLS:C1512523


subject: UMLS:C0443985

subject_name: Flinders medical centre-7 marker


subject: UMLS:C0443985


subject: UMLS:C0443985


subject: CHEBI:17883

subject_name: Hydrochloric acid


subject: CHEBI:17883


subject: CHEBI:17883


subject: CHEBI:157844

subject_name: Glu-Arg


subject: CHEBI:157844


subject: CHEBI:157844


subject: CHEBI:33379

subject_name: erbium


subject: CHEBI:33379


subject: CHEBI:33379


subject: UMLS:C5441529

subject_name: Estrogen Receptor Family, human


subject: UMLS:C5441529


subject: UMLS:C5441529


subject: PR:000007204

subject_name: estrogen receptor


subject: PR:000007204


subject: PR:000007204


subject: UNII:2S9ZZM9Q9V

subject_name: Bevacizumab

object_name: Malignant Ovarian Mixed Epithelial Tumor


subject: CHEBI:23123

subject_name: chloroacetate

object_name: Brugada syndrome


subject: CHEBI:23123

object_name: Brugada Syndrome Ventricular Arrhythmia by ECG Finding


subject: CHEBI:27869

subject_name: chloroacetic acid


subject: CHEBI:27869


subject: CHEBI:61080

subject_name: Romidepsin

object_name: Recurrent Childhood Ependymoma


subject: CHEBI:61080

object_name: recurrent childhood acute myeloid leukemia


subject: CHEBI:61080

object_name: Recurrent Childhood Medulloblastoma


subject: CHEBI:61080

object_name: Recurrent Childhood Brain Stem Glioma


subject: CHEBI:61080

object_name: Recurrent Childhood Acute Lymphoblastic Leukemia


subject: CHEBI:61080

object_name: Recurrent Childhood Cerebral Astrocytoma


subject: CHEBI:61080

object_name: Recurrent Childhood Cerebellar Astrocytoma


subject: CHEBI:61080

object_name: unspecified childhood solid tumor, protocol specific


subject: CHEBI:61080

object_name: recurrent childhood visual pathway and hypothalamic glioma


subject: CHEBI:61080

object_name: Blast Phase


subject: CHEBI:61080

object_name: Recurrent Childhood Supratentorial Embryonal Tumor, Not Otherwise Specified


subject: CHEBI:61080

object_name: Recurrent Chronic Myelogenous Leukemia, BCR-ABL1 Positive


subject: CHEBI:61080

object_name: Childhood Chronic Myelogenous Leukemia, BCR-ABL1 Positive


subject: CHEBI:61080

object_name: childhood central nervous system germ cell tumor


subject: CHEBI:61080

object_name: childhood choroid plexus neoplasm


subject: CHEBI:61080

object_name: pediatric infratentorial ependymoma


subject: CHEBI:61080

object_name: pediatric supratentorial ependymoma


subject: CHEBI:61080

object_name: Childhood Glioblastoma


subject: CHEBI:61080

object_name: childhood low-grade cerebral astrocytoma


subject: CHEBI:61080

object_name: Childhood Grade I Meningioma


subject: CHEBI:61080

object_name: childhood spinal cord tumor


subject: CHEBI:61080

object_name: Childhood Grade III Meningioma


subject: CHEBI:61080

object_name: Childhood Grade II Meningioma


subject: CHEBI:61080

object_name: Childhood Craniopharyngioma


subject: UMLS:C0963679

object_name: Recurrent Childhood Ependymoma


subject: UMLS:C0963679

object_name: recurrent childhood acute myeloid leukemia


subject: UMLS:C0963679

object_name: Recurrent Childhood Medulloblastoma


subject: UMLS:C0963679

object_name: Recurrent Childhood Brain Stem Glioma


subject: UMLS:C0963679

object_name: Recurrent Childhood Acute Lymphoblastic Leukemia


subject: UMLS:C0963679

object_name: Recurrent Childhood Cerebral Astrocytoma


subject: UMLS:C0963679

object_name: Recurrent Childhood Cerebellar Astrocytoma


subject: UMLS:C0963679

object_name: unspecified childhood solid tumor, protocol specific


subject: UMLS:C0963679

object_name: recurrent childhood visual pathway and hypothalamic glioma


subject: UMLS:C0963679

object_name: Blast Phase


subject: UMLS:C0963679

object_name: Recurrent Childhood Supratentorial Embryonal Tumor, Not Otherwise Specified


subject: UMLS:C0963679

object_name: Recurrent Chronic Myelogenous Leukemia, BCR-ABL1 Positive


subject: UMLS:C0963679

object_name: Childhood Chronic Myelogenous Leukemia, BCR-ABL1 Positive


subject: UMLS:C0963679

object_name: childhood central nervous system germ cell tumor


subject: UMLS:C0963679

object_name: childhood choroid plexus neoplasm


subject: UMLS:C0963679

object_name: pediatric infratentorial ependymoma


subject: UMLS:C0963679

object_name: pediatric supratentorial ependymoma


subject: UMLS:C0963679

object_name: Childhood Glioblastoma


subject: UMLS:C0963679

object_name: childhood low-grade cerebral astrocytoma


subject: UMLS:C0963679

object_name: Childhood Grade I Meningioma


subject: UMLS:C0963679

object_name: childhood spinal cord tumor


subject: UMLS:C0963679

object_name: Childhood Grade III Meningioma


subject: UMLS:C0963679

object_name: Childhood Grade II Meningioma


subject: UMLS:C0963679

object_name: Childhood Craniopharyngioma


subject: CHEBI:93775

subject_name: Amethopterin

object_name: Allogenic disease


subject: CHEBI:93775

object_name: complications of organ transplant stem cells


subject: CHEBI:93775

object_name: Graft vs Host Reaction


subject: CHEBI:50681


subject: CHEBI:50681


subject: CHEBI:50681


subject: CHEBI:44185

subject_name: Methotrexate


subject: CHEBI:44185


subject: CHEBI:44185


subject: CHEBI:68579

subject_name: Rivaroxaban

object_name: Acute Heart Failure Related to COVID-19


subject: CHEBI:68579

object_name: Acute heart failure


subject: CHEBI:192761

subject_name: Iron sucrose

object_name: Iron deficiency anemia of pregnancy


subject: UNII:0XT2CPR891

subject_name: BEFOTERTINIB

object_name: Metastatic non-small cell lung cancer


subject: UNII:0XT2CPR891


subject: DRUGBANK:DB18844

subject_name: Befotertinib


subject: DRUGBANK:DB18844


subject: UNII:9G6U5L461Q

subject_name: Icotinib


subject: UNII:9G6U5L461Q


subject: MESH:C000657265

object_name: Advanced Malignant Solid Neoplasm


subject: UMLS:C0085297

subject_name: immunoglobulins, intravenous

object_name: sickle cell disease


subject: UMLS:C0086333

subject_name: Gammagard


subject: CHEBI:35475

subject_name: non-steroidal anti-inflammatory drug

object_name: Anastomotic Leak


subject: UMLS:C0003211

subject_name: Anti-Inflammatory Agents, Non-Steroidal


subject: UMLS:C0358845

subject_name: Analgesics and non-steroidal anti-inflammatory drugs


subject: UMLS:C2825405

subject_name: Esmeron

object_name: Out-of-Hospital Cardiac Arrest


subject: CHEBI:8884

subject_name: Rocuronium


subject: CHEMBL.COMPOUND:CHEMBL4297912

subject_name: BIFIDOBACTERIUM SPP.

object_name: obesity due to melanocortin 4 receptor deficiency


subject: CHEMBL.COMPOUND:CHEMBL4297912

object_name: obesity


subject: CHEMBL.COMPOUND:CHEMBL4297912

object_name: Obesity, CTCAE


subject: CHEBI:85994

subject_name: Lenvatinib

object_name: Carcinoma breast stage IV


subject: CHEBI:91899

object_name: acute respiratory distress syndrome


subject: CHEBI:3207

subject_name: Budesonide


subject: CHEMBL.COMPOUND:CHEMBL2108494

subject_name: INTERFERON

object_name: Zollinger-Ellison syndrome


subject: CHEMBL.COMPOUND:CHEMBL2108494

object_name: pancreatic neuroendocrine neoplasm


subject: CHEMBL.COMPOUND:CHEMBL2108494

object_name: insulinoma


subject: UMLS:C3652465

subject_name: Interferon


subject: UMLS:C3652465


subject: UMLS:C3652465


subject: UMLS:C0021747

subject_name: Interferons


subject: UMLS:C0021747


subject: UMLS:C0021747


subject: UMLS:C0733470

subject_name: human leukocyte interferon


subject: UMLS:C0733470


subject: UMLS:C0733470


subject: CHEBI:8378

subject_name: Prednisolone

object_name: Crohn disease


subject: UNII:37KZM6S21G

subject_name: cerebrolysin

object_name: Acute Stroke


subject: UNII:37KZM6S21G

object_name: sequelae of; stroke


subject: UMLS:C0055108


subject: UMLS:C0055108


subject: CHEBI:4856

subject_name: Esmolol

object_name: Nausea, CTCAE_5


subject: CHEBI:4856

object_name: Nausea


subject: CHEBI:4856

object_name: Nausea, CTCAE_3


subject: CHEBI:4856

object_name: Vomiting, CTCAE


subject: CHEBI:4856

object_name: Vomiting


subject: CHEBI:4856

object_name: Constipation


subject: CHEBI:4856

object_name: Constipation, CTCAE


subject: CHEBI:4911

subject_name: Etoposide

object_name: Richter syndrome


subject: CHEBI:28748

subject_name: Doxorubicin


subject: CHEBI:8382

subject_name: Prednisone


subject: PUBCHEM.COMPOUND:155885731

subject_name: Maribavir

object_name: alkaptonuria


subject: CHEBI:15968

subject_name: Ompenaclid

object_name: Malignant neoplasm of colon stage IV


subject: CHEBI:3215

subject_name: Bupivacaine

object_name: Forearm Injuries


subject: CHEBI:147398

subject_name: Tideglusib

object_name: arrhythmogenic right ventricular cardiomyopathy


subject: UNII:47RRR83SK7

subject_name: [OBSOLETE] interferon alfa-2a

object_name: hepatitis B


subject: CHEBI:74538

subject_name: Leu-Gly-Gly

object_name: digestive system neoplasm


subject: CHEBI:74538

object_name: Neoplasm of the gastrointestinal tract


subject: UMLS:C0721277

subject_name: LGG brand of Dyphylline/Guaifenesin


subject: UMLS:C0721277


subject: UMLS:C1832078

subject_name: LGG Lactobacillus rhamnosus GG


subject: UMLS:C1832078


subject: CHEBI:2453

subject_name: Acyclovir

object_name: herpes simplex dermatitis


subject: CHEBI:2453

object_name: Herpes NOS


subject: CHEBI:94708

subject_name: Diacerein

object_name: Insulin resistance


subject: UMLS:C0350411

subject_name: Oxygen only product in gas for inhalation

object_name: Oxygen toxicity


subject: UMLS:C0350411

object_name: Hypoxemia


subject: CHEBI:175901

subject_name: Gemcitabine

object_name: Cervical carcinoma stage IVB


subject: CHEBI:175901

object_name: Stage IVB Cervical Cancer AJCC v6 and v7


subject: CHEBI:175901

object_name: Stage IVB Cervical Cancer AJCC v8


subject: CHEBI:175901

object_name: cervical squamous cell carcinoma


subject: CHEBI:175901

object_name: cervical adenosquamous carcinoma


subject: CHEBI:32296

subject_name: vinorelbine L-tartrate

object_name: Cervix carcinoma recurrent


subject: CHEBI:32296


subject: CHEBI:32296


subject: CHEBI:32296


subject: CHEBI:32296

object_name: cervical adenocarcinoma


subject: CHEBI:32296


subject: CHEBI:32296


subject: PUBCHEM.COMPOUND:16051941


subject: PUBCHEM.COMPOUND:16051941


subject: PUBCHEM.COMPOUND:16051941


subject: PUBCHEM.COMPOUND:16051941


subject: PUBCHEM.COMPOUND:16051941


subject: PUBCHEM.COMPOUND:16051941


subject: PUBCHEM.COMPOUND:16051941


subject: CHEBI:53750

subject_name: vinorelbine D-tartrate


subject: CHEBI:53750


subject: CHEBI:53750


subject: CHEBI:53750


subject: CHEBI:53750


subject: CHEBI:53750


subject: CHEBI:53750


subject: PUBCHEM.COMPOUND:44424639

subject_name: Vinorelbine


subject: PUBCHEM.COMPOUND:44424639


subject: PUBCHEM.COMPOUND:44424639


subject: PUBCHEM.COMPOUND:44424639


subject: PUBCHEM.COMPOUND:44424639


subject: PUBCHEM.COMPOUND:44424639


subject: PUBCHEM.COMPOUND:44424639


subject: CHEBI:93786


subject: CHEBI:93786


subject: CHEBI:93786


subject: CHEBI:93786


subject: CHEBI:93786


subject: CHEBI:93786


subject: CHEBI:93786


subject: UNII:KM31LBX59H

subject_name: Florbenazine F-18

object_name: type 2 diabetes mellitus


subject: UMLS:C2934037


subject: CHEBI:4466

subject_name: Dexmedetomidine

object_name: Chronic Insomnia


subject: UNII:7N8K34P2XH

subject_name: Detomidine


subject: UMLS:C2986994

object_name: ovarian cancer


subject: UMLS:C2986994

object_name: ovarian neoplasm


subject: UMLS:C2986994

object_name: ovarian carcinoma


subject: PUBCHEM.COMPOUND:136924190

subject_name: Guadecitabine


subject: PUBCHEM.COMPOUND:136924190


subject: PUBCHEM.COMPOUND:136924190


subject: UMLS:C2682458

subject_name: darifenacin 7.5 MG Extended Release Oral Tablet

object_name: frontotemporal dementia and/or amyotrophic lateral sclerosis 7


subject: UMLS:C2682458

object_name: amyotrophic lateral sclerosis


subject: UMLS:C0754326

subject_name: Optison

object_name: coronary artery disorder


subject: UMLS:C0754326

object_name: coronary atherosclerosis


subject: UMLS:C4727022

object_name: HER2 positive breast carcinoma


subject: UMLS:C0295415

subject_name: rituximab

object_name: Inflammation


subject: UNII:GKF8S4C432

subject_name: Anlotinib


subject: CHEBI:151315

subject_name: Heparin

object_name: Anticoagulant adverse reaction


subject: UNII:E47C0NF7LV

subject_name: ENOXAPARIN


subject: UNII:8NZ41MIK1O

subject_name: Enoxaparin


subject: UMLS:C4683561

subject_name: Immune Checkpoint Modulator

object_name: cancer


subject: UMLS:C4683561

object_name: neoplasm


subject: CHEBI:453011

subject_name: Ciclopirox

object_name: dermatomycosis


subject: UNII:09495UIM6V

subject_name: Bimekizumab

object_name: psoriasis


subject: UNII:9AU7XUV31A

object_name: multidrug-resistant tuberculosis


subject: CHEBI:188155


subject: UNII:9P1872D4OL

subject_name: Exenatide

object_name: Pediatric Obesity


subject: CHEBI:168243

subject_name: Valproic acid glucuronide

object_name: Status epilepticus without prominent motor symptoms


subject: CHEBI:39867

subject_name: Valproic acid


subject: UMLS:C0772283

subject_name: guarana preparation

object_name: neuroendocrine neoplasm


subject: UMLS:C0772283

object_name: female reproductive organ cancer


subject: CHEBI:9144

subject_name: Silibinin

object_name: hepatitis


subject: CHEBI:125451

subject_name: silymarin


subject: UNII:U946SH95EE

subject_name: Milk thistle

object_name: hepatitis A


subject: UNII:U946SH95EE


subject: UMLS:C4721782

subject_name: Pegargiminase

object_name: non-small cell squamous lung carcinoma


subject: UMLS:C4721782

object_name: sarcomatoid carcinoma


subject: UMLS:C4721782

object_name: glioma


subject: UMLS:C4721782

object_name: malignant glioma


subject: UMLS:C4721782

object_name: uveal melanoma


subject: UMLS:C4721782

object_name: malignant peritoneal mesothelioma


subject: UMLS:C4721782

object_name: Pleural mesothelioma malignant advanced


subject: UMLS:C1328192

subject_name: ADI PEG20


subject: UMLS:C1328192


subject: UMLS:C1328192


subject: UMLS:C1328192


subject: UMLS:C1328192


subject: UMLS:C1328192


subject: CHEBI:31824

subject_name: Mesna

object_name: Adult B Acute Lymphoblastic Leukemia with t(9;22)(q34.1;q11.2); BCR-ABL1


subject: CHEBI:31824

object_name: Childhood B Acute Lymphoblastic Leukemia with t(9;22)(q34.1;q11.2); BCR-ABL1


subject: CHEBI:31824

object_name: Ph-positive acute lymphoblastic leukemia


subject: CHEBI:17905

subject_name: Coenzyme M


subject: CHEBI:17905


subject: CHEBI:17905


subject: HMDB:HMDB0256702

subject_name: Porfimer Sodium

object_name: cholangiocarcinoma of the gallbladder


subject: HMDB:HMDB0256702

object_name: cholangiocarcinoma of the extrahepatic bile duct


subject: HMDB:HMDB0256702

object_name: Unresectable Gallbladder Carcinoma


subject: HMDB:HMDB0256702

object_name: Unresectable Extrahepatic Bile Duct Carcinoma


subject: HMDB:HMDB0256702

object_name: Recurrent Extrahepatic Bile Duct Carcinoma


subject: HMDB:HMDB0256702

object_name: Recurrent Cancer of Gallbladder


subject: HMDB:HMDB0256702

object_name: Malignant neoplasm of gallbladder recurrent


subject: UNII:Y3834SIK5F

subject_name: PORFIMER SODIUM


subject: UNII:Y3834SIK5F


subject: UNII:Y3834SIK5F


subject: UNII:Y3834SIK5F


subject: UNII:Y3834SIK5F


subject: UNII:Y3834SIK5F


subject: UNII:Y3834SIK5F


subject: CHEBI:107736

subject_name: Metoclopramide

object_name: Enteral feeding intolerance


subject: CHEBI:135552

subject_name: Prucalopride


subject: UMLS:C5959293

subject_name: SIRP-alpha-Fc Fusion Protein HCB101

object_name: colorectal cancer


subject: UMLS:C5959293

object_name: colorectal carcinoma


subject: CHEBI:7772

subject_name: omeprazole

object_name: gastritis h pylori


subject: UNII:L500PR95QA

subject_name: METRONIDAZOLE PHOSPHATE


subject: CHEBI:6909

subject_name: Metronidazole


subject: CHEBI:3374

subject_name: Capsaicin

object_name: stroke disorder


subject: CHEBI:3374

object_name: Stroke (heart beat)


subject: CHEBI:3374

object_name: Stroke, CTCAE


subject: UMLS:C2355853

object_name: Androgen excess


subject: UMLS:C1675748

object_name: Childhood Solid Neoplasm


subject: UMLS:C1675748

object_name: Adult Solid Neoplasm


subject: CHEBI:88249

subject_name: Mirdametinib


subject: UMLS:C1957666


subject: UMLS:C1957666


subject: UMLS:C1957666

object_name: Malignant neoplasm of cecum and/or colon and/or rectum (disorder)


subject: UMLS:C1957666


subject: UMLS:C1957666


subject: UMLS:C1957666

object_name: Solid Neoplasm


subject: UNII:B72HH48FLU

subject_name: Infliximab

object_name: scleritis


subject: MESH:C520497

subject_name: MoviPrep

object_name: digestive system disorder


subject: CHEBI:45716

subject_name: Vorinostat

object_name: Non-Neoplastic Hematopoietic and Lymphoid Cell Disorder


subject: CHEBI:9605

subject_name: Tirofiban

object_name: Non-ST Elevation Myocardial Infarction


subject: CHEBI:18248

subject_name: Iron

object_name: Nutritional anemia


subject: CHEBI:18248

object_name: Adolescent Development


subject: CHEBI:18248

object_name: Folate deficiency anemia due to dietary causes


subject: CHEBI:29034

subject_name: Ferric cation


subject: CHEBI:29034


subject: CHEBI:29034


subject: UMLS:C1166521

subject_name: Ferrum metallicum, Homeopathic preparation


subject: UMLS:C1166521


subject: UMLS:C1166521


subject: UMLS:C3714701

subject_name: Iron Drug Class


subject: UMLS:C3714701


subject: UMLS:C3714701


subject: CHEBI:27470

subject_name: Folic acid


subject: CHEBI:27470


subject: CHEBI:27470

object_name: anemia deficiency iron treatment


subject: CHEBI:27470


subject: DRUGBANK:DB17475

subject_name: Incomplete Freund's adjuvant


subject: DRUGBANK:DB17475


subject: DRUGBANK:DB17475


subject: DRUGBANK:DB17475


subject: CHEBI:6704

subject_name: Mebendazole


subject: CHEBI:6704


subject: CHEBI:6704


subject: CHEBI:6704


subject: CHEBI:3745

subject_name: clindamycin

object_name: chorioretinitis


subject: CHEBI:41879

subject_name: Dexamethasone


subject: UMLS:C3497397

subject_name: pyrimethamine / sulfadiazine


subject: CHEBI:8378

subject_name: Prednisolone


subject: CHEBI:82594

subject_name: Ferritin

object_name: retinopathy of prematurity


subject: CHEBI:82594

object_name: exudative vitreoretinopathy 1


subject: CHEBI:82594

object_name: Retinopathy of Prematurity, AE


subject: UMLS:C0013227

subject_name: Pharmaceutical Preparations

object_name: migraine


subject: UMLS:C0013227

object_name: migraine with or without aura, susceptibility to, 1


subject: UMLS:C1254351

subject_name: Pharmacologic Substance


subject: UMLS:C1254351


subject: CHEBI:23965

subject_name: estradiol


subject: CHEBI:23965


subject: UNII:31Z82G8ME1

subject_name: EDODEKIN ALFA

object_name: Metastatic Malignant Solid Neoplasm


subject: UNII:31Z82G8ME1

object_name: Unresectable Malignant Solid Neoplasm


subject: UMLS:C1328728


subject: UMLS:C1328728


subject: CHEBI:231601

subject_name: trastuzumab

object_name: breast carcinoma in situ


subject: UNII:SE2KH7T06F


subject: UMLS:C0338204

subject_name: Herceptin


subject: CHEBI:68841

subject_name: Gadobutrol

object_name: prostate adenocarcinoma


subject: UMLS:C1879711

subject_name: AMG 102

object_name: Adult Gliosarcoma


subject: UMLS:C1879711

object_name: gliosarcoma


subject: UMLS:C1879711

object_name: Childhood Gliosarcoma


subject: UMLS:C1879711

object_name: glioblastoma


subject: UMLS:C1879711

object_name: Brain Stem Glioblastoma


subject: UMLS:C1879711

object_name: glioma susceptibility 1


subject: UMLS:C2073830

subject_name: chlorothiazide injection

object_name: heart failure


subject: UMLS:C2073830

object_name: Heart Failure, CTCAE


subject: UMLS:C2073830

object_name: Heart failure with reduced ejection fraction


subject: UMLS:C2073830

object_name: Acute heart failure


subject: UMLS:C2073830

object_name: cardiovascular disorder


subject: CHEBI:3640

subject_name: Chlorothiazide


subject: CHEBI:3640


subject: CHEBI:3640


subject: CHEBI:64354

subject_name: Metolazone


subject: CHEBI:64354


subject: UMLS:C0521942

subject_name: Angiotensin II receptor antagonist

object_name: aortic stenosis


subject: UMLS:C0521942

object_name: aortic valve disease 2


subject: UMLS:C0521942

object_name: aortic valve disease 3


subject: UMLS:C0521942

object_name: Stenosis of aorta


subject: UMLS:C0815017

subject_name: Angiotensin Receptor Antagonists


subject: UMLS:C0815017


subject: UMLS:C0815017


subject: UMLS:C0815017


subject: CHEBI:233331

subject_name: Elamipretide

object_name: Barth syndrome


subject: UMLS:C4279623


subject: UMLS:C1569697

object_name: Childhood Brain Neoplasm


subject: UMLS:C1569697

object_name: brain cancer


subject: UMLS:C1569697

object_name: brain neoplasm


subject: CHEBI:94518

subject_name: Tranexamic acid

object_name: has nosebleeds - epistaxis


subject: CHEBI:73855

subject_name: Gly-Ala

object_name: Post-Operative Pain


subject: CHEBI:73855

object_name: Cognitive impairment


subject: CHEBI:73855

object_name: liver cancer


subject: CHEBI:73855

object_name: liver neoplasm


subject: CHEBI:73855

object_name: Adult Liver Carcinoma


subject: CHEBI:73855

object_name: liver carcinoma


subject: CHEBI:73891

subject_name: Gly-D-Ala


subject: CHEBI:73891


subject: CHEBI:73891


subject: CHEBI:73891


subject: CHEBI:73891


subject: CHEBI:73891


subject: CHEBI:5206

subject_name: GA


subject: CHEBI:5206


subject: CHEBI:5206


subject: CHEBI:5206


subject: CHEBI:5206


subject: CHEBI:5206


subject: CHEBI:28833

subject_name: gibberellin A3


subject: CHEBI:28833


subject: CHEBI:28833


subject: CHEBI:28833


subject: CHEBI:28833


subject: CHEBI:28833


subject: UMLS:C5200970

subject_name: Nerve agent GA


subject: UMLS:C5200970


subject: UMLS:C5200970


subject: UMLS:C5200970


subject: UMLS:C5200970


subject: UMLS:C5200970


subject: CHEBI:49631

subject_name: gallium atom


subject: CHEBI:49631


subject: CHEBI:49631


subject: CHEBI:49631


subject: CHEBI:49631


subject: CHEBI:49631


subject: PR:000008052

subject_name: glutaminase liver isoform, mitochondrial


subject: PR:000008052


subject: PR:000008052


subject: PR:000008052


subject: PR:000008052


subject: PR:000008052


subject: CHEBI:24433

subject_name: group


subject: CHEBI:24433


subject: CHEBI:24433


subject: CHEBI:24433


subject: CHEBI:24433


subject: CHEBI:24433


subject: PUBCHEM.COMPOUND:9848990

subject_name: BUPRENORPHINE

object_name: obesity due to congenital leptin deficiency


subject: PUBCHEM.COMPOUND:9848990

object_name: obesity due to leptin receptor gene deficiency


subject: PUBCHEM.COMPOUND:9848990

object_name: morbid obesity


subject: UMLS:C4032853

subject_name: Aptensio XR

object_name: attention deficit hyperactivity disorder, inattentive type


subject: CHEBI:9907

subject_name: ursodiol

object_name: age


subject: UNII:Z1HHM49K7O

subject_name: Napabucasin

object_name: colorectal cancer


subject: UNII:Z1HHM49K7O

object_name: colorectal carcinoma


subject: UNII:Z1HHM49K7O

object_name: Malignant neoplasm of cecum and/or colon and/or rectum (disorder)


subject: CHEBI:31905

subject_name: Nicorandil

object_name: ST-segment elevation myocardial infarction (STEMI)


subject: CHEBI:135652

subject_name: Flunarizine

object_name: Transformed migraine


subject: UNII:BKV67W3IO8

subject_name: Cesium Cs-131

object_name: Neck Carcinoma


subject: UNII:BKV67W3IO8

object_name: head and neck neoplasm


subject: UNII:BKV67W3IO8

object_name: head and neck cancer


subject: UNII:BKV67W3IO8

object_name: head and neck squamous cell carcinoma


subject: PUBCHEM.COMPOUND:9834332

subject_name: Brivaracetam

object_name: postherpetic neuralgia


subject: PUBCHEM.COMPOUND:14907381

subject_name: Fluoruracil

object_name: ERBB2 Gene Mutation


subject: CHEBI:190410

subject_name: 13-Demethyl tacrolimus


subject: CHEBI:46345

subject_name: Fluorouracil


subject: CHEBI:31348

subject_name: Capecitabine


subject: PUBCHEM.COMPOUND:43805

subject_name: Oxaliplatin


subject: UMLS:C1314429

subject_name: INJECTION, OXALIPLATIN, 0.5 MG ADMINISTERED


subject: CHEBI:15765

subject_name: Levodopa

object_name: mild neurocognitive disorder


subject: CHEBI:15765

object_name: mild cognitive impairment


subject: CHEBI:15765

object_name: Alzheimer disease


subject: UMLS:C2703114

object_name: childhood neoplasm


subject: UMLS:C2703114

object_name: neoplastic syndrome


subject: UMLS:C2703114

object_name: cancer or benign tumor


subject: CHEBI:75551


subject: CHEBI:75551


subject: CHEBI:75551


subject: CHEBI:75551

object_name: neoplasm


subject: UMLS:C1831945

subject_name: Clostridium Novyi-NT Spores


subject: CHEBI:44915

subject_name: Propofol


subject: CHEBI:9130

subject_name: Sevoflurane


subject: CHEBI:231614

subject_name: Nivolumab

object_name: EBV Infection


subject: UMLS:C2346820


subject: UMLS:C0358855

subject_name: Nicotine Transdermal Patch

object_name: Childhood Breast Carcinoma


subject: UMLS:C0358855

object_name: breast carcinoma


subject: UMLS:C0358855

object_name: breast cancer


subject: UMLS:C0358855

object_name: Chemotherapeutic Agent Toxicity


subject: UMLS:C0358855

object_name: hand-foot syndrome


subject: CHEBI:16347

subject_name: Levocarnitine

object_name: spinal cord injury


subject: PR:000001345

subject_name: endoglin

object_name: triple-negative breast carcinoma


subject: PR:000001345

object_name: Anatomic Stage II Breast Cancer AJCC v8


subject: PR:000001345

object_name: Prognostic Stage II Breast Cancer AJCC v8


subject: PR:000001345

object_name: Anatomic Stage IB Breast Cancer AJCC v8


subject: PR:000001345

object_name: Prognostic Stage IB Breast Cancer AJCC v8


subject: PR:000001345

object_name: Anatomic Stage IIA Breast Cancer AJCC v8


subject: PR:000001345

object_name: Anatomic Stage IIB Breast Cancer AJCC v8


subject: PR:000001345

object_name: Prognostic Stage IIB Breast Cancer AJCC v8


subject: PR:000001345

object_name: Prognostic Stage IIA Breast Cancer AJCC v8


subject: PR:000017525

subject_name: Y-box-binding protein 1


subject: PR:000017525


subject: PR:000017525


subject: PR:000017525


subject: PR:000017525


subject: PR:000017525


subject: PR:000017525


subject: PR:000017525


subject: PR:000017525


subject: CHEBI:5103

subject_name: Flumazenil

object_name: Hypoactive delirium


subject: CHEBI:39585

subject_name: Carbidopa

object_name: chronic idiopathic urticaria


subject: PUBCHEM.COMPOUND:521372

subject_name: Cannabidiol


subject: CHEBI:73604

subject_name: Lys-Gly

object_name: Recurrent Malignant Solid Neoplasm


subject: CHEBI:73604

object_name: Hodgkin's disease lymphocyte depletion type recurrent


subject: CHEBI:27013

subject_name: Tocopherol

object_name: Restless legs


subject: UMLS:C5882212

object_name: Overweight


subject: CHEBI:3160

subject_name: botulinum toxin type A

object_name: temporomandibular joint dysfunction syndrome


subject: MESH:C079198

subject_name: S 1 (combination)

object_name: carcinoma of biliary tract


subject: UNII:CUJ2MVI71Y

subject_name: Daclizumab

object_name: hairy cell leukemia


subject: UMLS:C0281549

subject_name: Zenapax


subject: CHEBI:73638

subject_name: Phe-Val


subject: UMLS:C0655013

subject_name: B3(Fv)-PE38KDEL recombinant immunotoxin


subject: UMLS:C0021084

subject_name: Immunotoxins


subject: CHEBI:5296

subject_name: Gemfibrozil

object_name: Parkinson disease


subject: PUBCHEM.COMPOUND:27991

subject_name: dAVP

object_name: Platelet dysfunction


subject: PUBCHEM.COMPOUND:16051933

subject_name: DESMOPRESSIN


subject: CHEBI:27470

subject_name: Folic acid

object_name: Oligoasthenospermia


subject: CHEBI:24848

subject_name: inositol


subject: CHEBI:74705

subject_name: Met-Leu

object_name: Diabetes, Autoimmune


subject: PR:000009425

subject_name: killer cell lectin-like receptor subfamily F member 1


subject: PR:000016318

subject_name: thrombopoietin


subject: CHEBI:231505

subject_name: gallium nitrate

object_name: adult lymphoma


subject: CHEBI:231505

object_name: lymphoma


subject: CHEBI:231505

object_name: pediatric lymphoma


subject: CHEBI:231505

object_name: Childhood Neuroblastoma


subject: CHEBI:231505

object_name: neuroblastoma


subject: CHEBI:231505

object_name: malignant soft tissue neoplasm


subject: CHEBI:231505

object_name: sarcoma


subject: CHEBI:231505

object_name: unspecified childhood solid tumor, protocol specific


subject: UNII:Y2V2R4W9TQ

subject_name: Gallium nitrate


subject: UNII:Y2V2R4W9TQ


subject: UNII:Y2V2R4W9TQ


subject: UNII:Y2V2R4W9TQ


subject: UNII:Y2V2R4W9TQ


subject: UNII:Y2V2R4W9TQ


subject: UNII:Y2V2R4W9TQ


subject: UNII:Y2V2R4W9TQ


subject: CHEBI:49631

subject_name: gallium atom


subject: CHEBI:49631


subject: CHEBI:49631


subject: CHEBI:49631


subject: CHEBI:49631


subject: CHEBI:49631


subject: CHEBI:49631


subject: CHEBI:49631


subject: UMLS:C5709355

object_name: frontotemporal dementia and/or amyotrophic lateral sclerosis 7


subject: UMLS:C5709355

object_name: amyotrophic lateral sclerosis


subject: DRUGBANK:DB17007

subject_name: Alirinetide


subject: DRUGBANK:DB17007


subject: PR:000014353

subject_name: receptor-transporting protein 1


subject: PR:000014353


subject: UMLS:C5447434

subject_name: Tempol-containing MBM-02

object_name: glioblastoma


subject: UMLS:C5447434

object_name: Childhood Glioblastoma


subject: UMLS:C5447434

object_name: adult glioblastoma


subject: UMLS:C5447434

object_name: Brain Stem Glioblastoma


subject: UMLS:C5447434

object_name: glioma susceptibility 1


subject: UMLS:C2348288

subject_name: Dietary Zinc

object_name: Growth & development aspects


subject: CHEBI:29105

subject_name: Velmanase alfa


subject: CHEBI:27363

subject_name: Zinc


subject: UMLS:C3541396

subject_name: Zinc Supplements


subject: UMLS:C3714650

subject_name: Zinc Drug Class


subject: CHEBI:124959

subject_name: Tilarginine

object_name: Cirrhosis


subject: UMLS:C0069477


subject: CHEBI:229220

subject_name: Repotrectinib

object_name: Non-small cell lung cancer stage III


subject: CHEBI:229220

object_name: Metastatic non-small cell lung cancer


subject: DRUGBANK:DB17107

subject_name: Lifileucel

object_name: head and neck squamous cell carcinoma


subject: UMLS:C5577550

subject_name: nivolumab / relatlimab


subject: UMLS:C5577550

object_name: non-small cell lung carcinoma


subject: UMLS:C5577550

object_name: metastatic melanoma


subject: UMLS:C1130494

subject_name: Seretide

object_name: bronchiolitis obliterans syndrome


subject: UMLS:C1130494

object_name: complications of organ transplant stem cells


subject: UMLS:C1130494

object_name: respiratory system disorder


subject: CHEBI:35341

subject_name: steroid

object_name: meralgia paresthetica


subject: UMLS:C5782153

subject_name: Steroid [EPC]


subject: CHEBI:41879

subject_name: Dexamethasone


subject: PUBCHEM.COMPOUND:131769963

subject_name: Digoxigenin monodigitoxoside

object_name: keloid


subject: UNII:5XYK65KIGD


subject: CHEBI:50924

subject_name: Sorafenib


subject: MESH:C000619755

object_name: psoriasis vulgaris


subject: CHEBI:37144

subject_name: epichlorohydrin

object_name: Angina pectoris


subject: CHEBI:28364

subject_name: Icosapent


subject: PR:000016352

subject_name: metalloproteinase inhibitor 1


subject: UNII:2S9ZZM9Q9V

subject_name: Bevacizumab

object_name: Stage IIIC Colorectal Cancer AJCC v7


subject: UNII:2S9ZZM9Q9V

object_name: Stage III Colorectal Cancer AJCC v7


subject: UNII:2S9ZZM9Q9V

object_name: Stage IIIB Colorectal Cancer AJCC v7


subject: CHEBI:31348

subject_name: Capecitabine


subject: CHEBI:31348

object_name: Stage IV Colorectal Cancer AJCC v7


subject: CHEBI:31348


subject: CHEBI:31348

object_name: Stage IVA Colorectal Cancer AJCC v7


subject: CHEBI:31348

object_name: Stage IVB Colorectal Cancer AJCC v7


subject: CHEBI:31348


subject: UNII:DPT0O3T46P

subject_name: Pembrolizumab


subject: UNII:DPT0O3T46P

object_name: Mismatch Repair Protein Proficient


subject: CHEBI:75045

subject_name: Dabrafenib

object_name: CNS metastases


subject: CHEBI:6801

subject_name: Metformin

object_name: adenocarcinoma in situ of rectum


subject: CHEBI:33380

subject_name: thulium atom

object_name: Childhood Breast Carcinoma


subject: CHEBI:33380

object_name: breast carcinoma


subject: CHEBI:33380

object_name: breast cancer


subject: CHEBI:19226


subject: CHEBI:19226


subject: CHEBI:19226


subject: CHEBI:74861

subject_name: Thr-Met


subject: CHEBI:74861


subject: CHEBI:74861


subject: CHEBI:55460

subject_name: trimellityl group


subject: CHEBI:55460


subject: CHEBI:55460


subject: UMLS:C3166394

subject_name: Tm antigen


subject: UMLS:C3166394


subject: UMLS:C3166394


subject: PR:000002105

subject_name: thrombomodulin


subject: PR:000002105


subject: PR:000002105


subject: UMLS:C1831752

subject_name: Sorbolene


subject: UMLS:C1831752


subject: UMLS:C1831752


subject: PUBCHEM.COMPOUND:2767

subject_name: Cisplatin

object_name: Cisplatin adverse reaction


subject: UMLS:C1120338

subject_name: casein phosphopeptide-amorphous calcium phosphate nanocomplex

object_name: tooth erosion


subject: UNII:7D0YB67S97

subject_name: Abatacept

object_name: multiple sclerosis


subject: CHEBI:94789

subject_name: Trimetazidine

object_name: Mitochondrial pathology


subject: CHEBI:94789

object_name: ATTRV122I amyloidosis


subject: CHEBI:6801

object_name: c.pregnancy; prediabetes


subject: CHEBI:192842

subject_name: Methoxyamine

object_name: Adult Brain Glioblastoma


subject: CHEBI:37941

subject_name: Clopidogrel

object_name: diabetes mellitus


subject: UNII:T9FVH03HMZ

subject_name: Calaspargase pegol

object_name: leukemia


subject: UNII:T9FVH03HMZ

object_name: childhood leukemia


subject: CHEBI:135925

subject_name: Lisdexamfetamine

object_name: myalgic encephalomeyelitis/chronic fatigue syndrome


subject: PUBCHEM.COMPOUND:73151030

subject_name: Empagliflozin

object_name: post-operative atrial fibrillation


subject: CHEBI:31547

subject_name: Eplerenone

object_name: Cardiac steatosis


subject: CHEBI:31547

object_name: Fatty Liver


subject: CHEBI:6128

subject_name: Ketoprofen

object_name: Complication of other surgical procedures


subject: CHEBI:7772

subject_name: omeprazole


subject: PUBCHEM.COMPOUND:9852982

subject_name: Ceftaroline

object_name: Infection


subject: PUBCHEM.COMPOUND:9852982

object_name: infectious disease


subject: PUBCHEM.COMPOUND:9852982

object_name: Adverse Event Associated with Infection


subject: PUBCHEM.COMPOUND:72562361

subject_name: Ceftaroline fosamil


subject: PUBCHEM.COMPOUND:72562361


subject: CHEBI:74757

subject_name: Pro-Gln

object_name: Malaria, Vivax


subject: CHEBI:16797

subject_name: Trigonellamide

object_name: hypertriglyceridemia


subject: CHEBI:16797

object_name: Hypertriglyceridemia, CTCAE


subject: UMLS:C4053665

object_name: grade II glioma


subject: UMLS:C4053665

object_name: low grade glioma


subject: UMLS:C4053665

object_name: malignant glioma


subject: UMLS:C4053665

object_name: grade III glioma


subject: UMLS:C4053665

object_name: IDH1 gene mutation


subject: UMLS:C4053665

object_name: IDH2 gene mutation


subject: UMLS:C4053665

object_name: glioblastoma


subject: UMLS:C4053665

object_name: Childhood Glioblastoma


subject: UMLS:C4053665

object_name: adult glioblastoma


subject: UMLS:C0919079

subject_name: TEMOZOLOMIDE, ORAL, 5 MG ADMINISTERED


subject: UMLS:C0919079


subject: CHEBI:72564

subject_name: Temozolomide


subject: CHEBI:72564


subject: CHEBI:37941

object_name: gastric ulcer


subject: CHEBI:37941

object_name: Gastric Ulcer, CTCAE


subject: CHEBI:37941

object_name: duodenal ulcer


subject: CHEBI:37941

object_name: Duodenal Ulcer, CTCAE


subject: UNII:8202AY8I7H

subject_name: Eptinezumab

object_name: Migraine in children


subject: CHEBI:31911

subject_name: Nilvadipine

object_name: Alzheimer disease


subject: CHEBI:6704

subject_name: Mebendazole

object_name: trichuriasis


subject: PUBCHEM.COMPOUND:24868177

subject_name: neuropeptide Y

object_name: post-traumatic stress disorder


subject: CHEBI:80201

subject_name: Neuropeptide Y


subject: PR:000011387


subject: PUBCHEM.COMPOUND:6096882

subject_name: indocyanine green

object_name: lymph node disorder


subject: UNII:C4V974V932

subject_name: Indocyanine green acid form


subject: CHEBI:15773

subject_name: cyclohexylamine

object_name: metastatic colorectal cancer


subject: UMLS:C5203461

subject_name: Paricalcitol Liquid Injection

object_name: end stage renal failure


subject: UMLS:C5203461

object_name: Chronic uremia


subject: UNII:3M6325NY1R

subject_name: Iron isomaltoside 1000

object_name: carcinoma of esophagus


subject: UNII:3M6325NY1R

object_name: esophageal cancer


subject: UNII:3M6325NY1R

object_name: Childhood Esophageal Carcinoma


subject: UNII:3M6325NY1R

object_name: neoplasm of esophagus


subject: UNII:3M6325NY1R

object_name: Stomach cancer


subject: UNII:3M6325NY1R

object_name: gastric cancer


subject: CHEBI:77572

subject_name: Tranilast

object_name: Esophageal stricture


subject: CHEBI:77572


subject: CHEBI:6801

subject_name: Metformin

object_name: Benign thyroid nodule


subject: UMLS:C3496181

subject_name: white rice extract

object_name: hyperlipidemia


subject: UMLS:C3496181

object_name: hyperlipoproteinemia


subject: UMLS:C3496181

object_name: Hyperlipidemia, CTCAE


subject: UMLS:C3496181

object_name: Serum lipids high (finding)


subject: UMLS:C3496181

object_name: hyperglycemia


subject: UMLS:C3496181

object_name: Hyperglycemia, CTCAE


subject: UMLS:C3496181

object_name: Glucose in blood specimen above reference range


subject: UMLS:C3496181

object_name: type 2 diabetes mellitus


subject: CHEBI:135901

subject_name: lanreotide

object_name: prostate carcinoma


subject: CHEBI:135901

object_name: prostate cancer


subject: UMLS:C0051846

subject_name: angiopeptin


subject: UMLS:C0051846


subject: MESH:D057466

subject_name: Nonsteroidal Anti-Androgens


subject: MESH:D057466


subject: CHEBI:31236

subject_name: Aripiprazole


subject: CHEBI:31236

object_name: Skin-picking


subject: PUBCHEM.COMPOUND:5339

subject_name: Sulfasalazine

object_name: coronary artery disorder


subject: PUBCHEM.COMPOUND:5339

object_name: coronary atherosclerosis


subject: CHEBI:136052

subject_name: Lobeglitazone

object_name: Decreased liver function


subject: UMLS:C2744791

subject_name: CKD 501


subject: UMLS:C1709400

object_name: neoplasm


subject: CHEBI:100241

subject_name: Ciprofloxacin

object_name: periapical periodontitis


subject: CHEBI:119915

subject_name: Fentanyl

object_name: atrial fibrillation


subject: CHEBI:6931

subject_name: Midazolam


subject: CHEBI:31627

subject_name: FP 83


subject: CHEMBL.COMPOUND:CHEMBL2108577

subject_name: BELAGENPUMATUCEL-L

object_name: non-small cell lung carcinoma


subject: MESH:C514428

subject_name: belagenpumatucel L


subject: PUBCHEM.COMPOUND:6323481

subject_name: phosphatidylserine

object_name: Cognitive changes


subject: KEGG.COMPOUND:C02737

subject_name: Phosphatidylserine


subject: CHEBI:18303


subject: PUBCHEM.COMPOUND:124037376

object_name: herpes zoster


subject: PUBCHEM.COMPOUND:124037376

object_name: postherpetic neuralgia


subject: CHEMBL.COMPOUND:CHEMBL4297775


subject: CHEMBL.COMPOUND:CHEMBL4297775


subject: UMLS:C3712782


subject: UMLS:C3712782


subject: PR:000001379

object_name: Stage III Cutaneous Melanoma AJCC v6


subject: UNII:25E79B5CTM

subject_name: Denileukin diftitox


subject: UNII:25E79B5CTM

object_name: Melanoma recurrent


subject: UMLS:C0211023


subject: UMLS:C0211023


subject: UNII:PQX0D8J21J

subject_name: Cetuximab

object_name: thymoma


subject: UNII:PQX0D8J21J

object_name: thymus neoplasm


subject: UNII:PQX0D8J21J

object_name: type C thymoma


subject: UMLS:C0879636

subject_name: IMC C225


subject: UMLS:C0879636


subject: UMLS:C0879636


subject: UMLS:C1541476

subject_name: AMG 706


subject: UMLS:C4733597

object_name: Coronavinae infectious disease


subject: UMLS:C4733597

object_name: cytokine release syndrome


subject: UMLS:C4733597

object_name: Cytokine Release Syndrome, CTCAE


subject: UMLS:C4733597

object_name: Cytokine storm


subject: UMLS:C4733597

object_name: familial acute respiratory distress syndrome, ANLN-related, dog


subject: UMLS:C4733597

object_name: acute respiratory distress syndrome


subject: UMLS:C4733597

object_name: COVID-19-Associated Acute Respiratory Distress Syndrome


subject: UMLS:C4733597

object_name: adult acute respiratory distress syndrome


subject: UMLS:C0002521

subject_name: Amino Acids, Branched-Chain

object_name: Frail elderly syndrome


subject: UMLS:C3537265

subject_name: LY573636 sodium

object_name: sarcoma


subject: UMLS:C3537265

object_name: soft tissue sarcoma


subject: UMLS:C0591333

subject_name: Deltacortril

object_name: Scrofula


subject: UNII:7D0YB67S97

subject_name: Abatacept

object_name: hematopoietic and lymphoid system neoplasm


subject: UMLS:C0378942


subject: CHEBI:70839

subject_name: Dasatinib

object_name: Motor function (finding)


subject: CHEBI:70839

object_name: Sedentary lifestyle


subject: CHEBI:70839

object_name: Mental deterioration


subject: CHEBI:70839

object_name: Cognitive impairment


subject: CHEBI:190514


subject: CHEBI:190514


subject: CHEBI:190514


subject: CHEBI:190514


subject: CHEBI:49375


subject: CHEBI:49375


subject: CHEBI:49375


subject: CHEBI:49375


subject: CHEBI:57694


subject: CHEBI:57694


subject: CHEBI:16243

subject_name: Quercetin


subject: CHEBI:16243


subject: CHEBI:50733

subject_name: nutraceutical


subject: CHEBI:50733


subject: CHEBI:50733


subject: CHEBI:76016

subject_name: Vortioxetine


subject: CHEBI:76016


subject: CHEBI:76016


subject: UMLS:C0250480

subject_name: piperacillin-tazobactam combination

object_name: neonatal sepsis


subject: UMLS:C0250480

object_name: Bacterial sepsis of newborn


subject: CHEBI:84739


subject: CHEBI:84739


subject: CHEBI:2637

subject_name: Amikacin


subject: CHEBI:2637


subject: UMLS:C1831860

subject_name: Beneo Synergy 1

object_name: celiac disease


subject: UMLS:C0728976

subject_name: Control brand of phenylpropanolamine

object_name: abdominal obesity-metabolic syndrome


subject: UMLS:C0728976

object_name: metabolic syndrome X


subject: UMLS:C0308718

subject_name: CONTROL veterinary product


subject: UMLS:C0308718


subject: UMLS:C1550141

subject_name: control substance


subject: UMLS:C1550141


subject: CHEBI:34549

subject_name: Fosravuconazole

object_name: mycetoma


subject: UMLS:C4289971

subject_name: Anti-PD-L1 Monoclonal Antibody

object_name: Colon Neoplasm


subject: UMLS:C4289971

object_name: benign colon neoplasm


subject: CHEBI:31348

subject_name: Capecitabine


subject: UNII:Q3NN3EB8VY

subject_name: CLOSTRIDIUM BUTYRICUM


subject: UNII:Q3NN3EB8VY


subject: PUBCHEM.COMPOUND:43805

subject_name: Oxaliplatin


subject: UMLS:C1314429

subject_name: INJECTION, OXALIPLATIN, 0.5 MG ADMINISTERED


subject: UNII:612BYT76F3

object_name: endogenous depression


subject: UNII:612BYT76F3

object_name: major depressive disorder


subject: CHEBI:6801

subject_name: Metformin

object_name: Glucose Intolerance, CTCAE


subject: CHEBI:34945

object_name: Parkinson disease


subject: UNII:7662KG2R6K

subject_name: Lubiprostone


subject: PUBCHEM.COMPOUND:54214995

subject_name: Sacubitril

object_name: connective tissue disorder


subject: PUBCHEM.COMPOUND:54214995

object_name: Myocardial injury


subject: CHEBI:9927

subject_name: Valsartan


subject: CHEBI:9927


subject: UMLS:C5564621

object_name: malaria


subject: UMLS:C5564621

object_name: Plasmodium falciparum infection


subject: UMLS:C0242937

subject_name: Analgesics, Non-Narcotic

object_name: bariatric surgery candidate


subject: UMLS:C0242937

object_name: Opioid use, unspecified


subject: UMLS:C3827186

subject_name: Jobelyn

object_name: anemia


subject: UMLS:C3827186

object_name: Anemia, CTCAE


subject: PR:000008945

subject_name: insulin-like growth factor 2 mRNA-binding protein 3

object_name: Stomach cancer


subject: PR:000008945

object_name: gastric cancer


subject: CHEBI:168396

subject_name: Mycophenolic acid

object_name: Sicca Syndrome


subject: CHEBI:8764

subject_name: Mycophenolate mofetil


subject: PUBCHEM.COMPOUND:9916099

subject_name: Letermovir

object_name: Transplant-Related Disorder


subject: PUBCHEM.COMPOUND:92043599

subject_name: epoetin alfa

object_name: optic neuritis


subject: CHEBI:81579

subject_name: Erythropoietin


subject: PUBCHEM.COMPOUND:4715169

subject_name: 3-(Aminomethyl)-5-methylhexanoic acid

object_name: Dysesthesia


subject: PUBCHEM.COMPOUND:4715169

object_name: Reported history of chronic illness


subject: PUBCHEM.COMPOUND:4715169

object_name: Chronic Disease


subject: CHEBI:64356

subject_name: Pregabalin


subject: CHEBI:64356


subject: CHEBI:64356


subject: UNII:R30772KCU0

subject_name: Isatuximab

object_name: adult lymphoma


subject: UNII:R30772KCU0

object_name: lymphoma


subject: UNII:R30772KCU0

object_name: pediatric lymphoma


subject: UNII:R30772KCU0

object_name: Adult Non-Hodgkin Lymphoma


subject: UNII:R30772KCU0

object_name: Childhood Non-Hodgkin Lymphoma


subject: UNII:R30772KCU0

object_name: Recurrent Adult Hodgkin Lymphoma


subject: UMLS:C2983777


subject: UMLS:C2983777


subject: UMLS:C2983777


subject: UMLS:C2983777


subject: UMLS:C2983777


subject: UMLS:C2983777


subject: CHEBI:116735

subject_name: Benzocaine

object_name: otitis media


subject: CHEBI:116735

object_name: Otitis Media, CTCAE


subject: CHEBI:36791

subject_name: Escitalopram

object_name: irritable bowel syndrome with constipation


subject: CHEBI:3723

subject_name: Citalopram


subject: PUBCHEM.COMPOUND:73151030

subject_name: Empagliflozin

object_name: proteinuria


subject: PUBCHEM.COMPOUND:73151030

object_name: Proteinuria of undiagnosed cause


subject: PUBCHEM.COMPOUND:73151030

object_name: Proteinuria, CTCAE 3.0


subject: PUBCHEM.COMPOUND:73151030

object_name: Proteinuria, CTCAE 5.0


subject: PUBCHEM.COMPOUND:73151030

object_name: glomerulonephritis


subject: UMLS:C4309853

subject_name: divaza

object_name: cerebral atherosclerosis


subject: PUBCHEM.COMPOUND:24743758

object_name: nicotine dependence


subject: MESH:C519271

subject_name: bivatuzumab mertansine

object_name: squamous cell carcinoma


subject: UMLS:C0939788

subject_name: Zometa

object_name: nasopharyngeal carcinoma


subject: UMLS:C0939788

object_name: nasopharyngeal carcinoma, susceptibility to, 1


subject: UMLS:C0939788

object_name: malignant tumor of nasopharynx


subject: CHEBI:46557

subject_name: Zoledronic acid


subject: CHEBI:46557


subject: CHEBI:46557


subject: UNII:6XC1PAD3KF

subject_name: ZOLEDRONIC ACID


subject: UNII:6XC1PAD3KF


subject: UNII:6XC1PAD3KF


subject: UNII:T8B02RAU3C

object_name: osteoarthritis


subject: CHEBI:3215

subject_name: Bupivacaine

object_name: Disorder of shoulder


subject: CHEBI:23965

subject_name: estradiol

object_name: type 1 diabetes mellitus


subject: CHEBI:6715

subject_name: medroxyprogesterone


subject: CHEBI:17650

subject_name: Hydrocortisone


subject: CHEBI:37845

subject_name: growth hormone


subject: CHEBI:169956

subject_name: Gly-His


subject: UNII:NQX9KB6PCL

subject_name: Somatotropin


subject: UniProtKB:P12824

subject_name: GH_HCMVA Envelope glycoprotein H (sprot)


subject: PR:000007957

subject_name: gamma-glutamyl hydrolase


subject: UMLS:C0037663

subject_name: Growth Hormone


subject: PR:000007968

subject_name: somatotropin


subject: CHEBI:229764

subject_name: Selinexor

object_name: Castration Levels of Testosterone


subject: CHEBI:229764

object_name: hormone-resistant prostate carcinoma


subject: CHEBI:229764

object_name: Prostate Carcinoma Metastatic in the Bone


subject: CHEBI:229764

object_name: Prostate Carcinoma Metastatic in the Soft Tissue


subject: CHEBI:229764

object_name: Adenocarcinoma of the prostate stage IV


subject: CHEBI:229764

object_name: PSA Progression


subject: CHEBI:37144

subject_name: epichlorohydrin

object_name: Duchenne muscular dystrophy


subject: CHEBI:28364

subject_name: Icosapent


subject: PR:000016352

subject_name: metalloproteinase inhibitor 1


subject: CHEBI:36005

subject_name: docosahexaenoic acid


subject: CHEBI:16016

subject_name: Glycerone


subject: CHEBI:28689

subject_name: Prasterone


subject: CHEBI:28125

subject_name: Doconexent


subject: CHEBI:86465

subject_name: Kalinite

object_name: Lyme disease


subject: UNII:I7T908772F

subject_name: alum


subject: CHEBI:86463

subject_name: Potassium alum


subject: UMLS:C1875730

subject_name: RINGER'S

object_name: Ischemic stroke


subject: UMLS:C1875730

object_name: intracerebral hemorrhage


subject: CHEBI:36005

object_name: macular degeneration


subject: CHEBI:36005

object_name: retinitis pigmentosa 30


subject: CHEBI:28125


subject: CHEBI:28125


subject: CHEBI:16016


subject: CHEBI:16016


subject: CHEBI:28689


subject: CHEBI:28689


subject: CHEBI:50733

subject_name: nutraceutical


subject: CHEBI:50733

object_name: age-related macular degeneration


subject: CHEBI:50733


subject: UNII:4A2Y23XK11

subject_name: Lazertinib

object_name: Non-small cell lung cancer stage III


subject: UNII:4A2Y23XK11

object_name: Epidermal growth factor receptor positive non-small cell lung cancer


subject: UMLS:C1384663

object_name: non-small cell lung carcinoma


subject: UNII:6GNT3Y5LMF

subject_name: LEVOFLOXACIN

object_name: Primary malignant neoplasm


subject: CHEBI:63598

subject_name: Levofloxacin


subject: PUBCHEM.COMPOUND:154496136

subject_name: Allin

object_name: prostate carcinoma


subject: PUBCHEM.COMPOUND:154496136

object_name: prostate cancer


subject: CHEBI:47808

subject_name: Sulforaphane


subject: CHEBI:47808


subject: CHEBI:44915

subject_name: Propofol

object_name: eosinophilic esophagitis


subject: CHEBI:44915

object_name: Eosinophilic infiltration of the esophagus


subject: CHEBI:74076

subject_name: Ile-Pro


subject: CHEBI:74076


subject: CHEBI:82335


subject: CHEBI:82335


subject: CHEBI:17660

subject_name: ENADENINE


subject: CHEBI:17660


subject: UMLS:C4049997


subject: UMLS:C4049997


subject: PR:000014564

subject_name: succinate dehydrogenase [ubiquinone] iron-sulfur subunit, mitochondrial


subject: PR:000014564


subject: CHEBI:9130

subject_name: Sevoflurane


subject: CHEBI:9130


subject: CHEBI:74078

subject_name: Ile-Ser


subject: CHEBI:74078


subject: GTOPDB:12990

subject_name: sintilimab

object_name: Microsatellite Stable


subject: GTOPDB:12990

object_name: RAS Family Gene Mutation


subject: CHEMBL.COMPOUND:CHEMBL4297829

subject_name: SINTILIMAB


subject: CHEMBL.COMPOUND:CHEMBL4297829


subject: UMLS:C4329335

subject_name: IBI 308


subject: UMLS:C4329335


subject: UMLS:C4733573

object_name: Advanced cancer


subject: PUBCHEM.COMPOUND:139350422

subject_name: Zanzalintinib

object_name: Refractory Differentiated Thyroid Gland Carcinoma


subject: PUBCHEM.COMPOUND:139350422

object_name: Locally Advanced Differentiated Thyroid Gland Carcinoma


subject: PUBCHEM.COMPOUND:139350422

object_name: Metastatic Differentiated Thyroid Gland Carcinoma


subject: PUBCHEM.COMPOUND:139350422

object_name: Locally Advanced Thyroid Gland Oncocytic Carcinoma


subject: PUBCHEM.COMPOUND:139350422

object_name: Metastatic Poorly Differentiated Thyroid Gland Carcinoma


subject: PUBCHEM.COMPOUND:139350422

object_name: Stage IV Differentiated Thyroid Gland Carcinoma AJCC v8


subject: PUBCHEM.COMPOUND:139350422

object_name: Stage III Differentiated Thyroid Gland Carcinoma AJCC v8


subject: PUBCHEM.COMPOUND:139350422

object_name: Refractory Thyroid Gland Papillary Carcinoma


subject: PUBCHEM.COMPOUND:139350422

object_name: Metastatic Thyroid Gland Oncocytic Carcinoma


subject: PUBCHEM.COMPOUND:139350422

object_name: Metastatic Thyroid Gland Papillary Carcinoma


subject: PUBCHEM.COMPOUND:139350422

object_name: Refractory Thyroid Gland Oncocytic Carcinoma


subject: PUBCHEM.COMPOUND:139350422

object_name: Metastatic Thyroid Gland Follicular Carcinoma


subject: PUBCHEM.COMPOUND:139350422

object_name: Refractory Thyroid Gland Follicular Carcinoma


subject: PUBCHEM.COMPOUND:139350422

object_name: Stage III Thyroid Gland Papillary Carcinoma AJCC v8


subject: PUBCHEM.COMPOUND:139350422

object_name: Stage III Thyroid Gland Follicular Carcinoma AJCC v8


subject: PUBCHEM.COMPOUND:139350422

object_name: Stage IV Thyroid Gland Papillary Carcinoma AJCC v8


subject: PUBCHEM.COMPOUND:139350422

object_name: Stage IV Thyroid Gland Follicular Carcinoma AJCC v8


subject: UNII:KC2JC2ZA04

subject_name: ZANZALINTINIB

object_name: Refractory Differentiated Thyroid Gland Carcinoma


subject: UNII:KC2JC2ZA04

object_name: Locally Advanced Differentiated Thyroid Gland Carcinoma


subject: UNII:KC2JC2ZA04

object_name: Metastatic Differentiated Thyroid Gland Carcinoma


subject: UNII:KC2JC2ZA04

object_name: Locally Advanced Thyroid Gland Oncocytic Carcinoma


subject: UNII:KC2JC2ZA04

object_name: Metastatic Poorly Differentiated Thyroid Gland Carcinoma


subject: UNII:KC2JC2ZA04

object_name: Stage IV Differentiated Thyroid Gland Carcinoma AJCC v8


subject: UNII:KC2JC2ZA04

object_name: Stage III Differentiated Thyroid Gland Carcinoma AJCC v8


subject: UNII:KC2JC2ZA04

object_name: Refractory Thyroid Gland Papillary Carcinoma


subject: UNII:KC2JC2ZA04

object_name: Metastatic Thyroid Gland Oncocytic Carcinoma


subject: UNII:KC2JC2ZA04

object_name: Metastatic Thyroid Gland Papillary Carcinoma


subject: UNII:KC2JC2ZA04

object_name: Refractory Thyroid Gland Oncocytic Carcinoma


subject: UNII:KC2JC2ZA04

object_name: Metastatic Thyroid Gland Follicular Carcinoma


subject: UNII:KC2JC2ZA04

object_name: Refractory Thyroid Gland Follicular Carcinoma


subject: UNII:KC2JC2ZA04

object_name: Stage III Thyroid Gland Papillary Carcinoma AJCC v8


subject: UNII:KC2JC2ZA04

object_name: Stage III Thyroid Gland Follicular Carcinoma AJCC v8


subject: UNII:KC2JC2ZA04

object_name: Stage IV Thyroid Gland Papillary Carcinoma AJCC v8


subject: UNII:KC2JC2ZA04

object_name: Stage IV Thyroid Gland Follicular Carcinoma AJCC v8


subject: UNII:5S371K6132

subject_name: Rivoceranib

object_name: Recurrence


subject: UNII:5S371K6132

object_name: Recurrent Malignant Neoplasm


subject: UNII:5S371K6132

object_name: Recurrent disease


subject: UNII:5S371K6132

object_name: Recurrent tumor


subject: UNII:YFZ7N482WG

object_name: diffuse large B-cell lymphoma


subject: UNII:YFZ7N482WG

object_name: Lymphoma, Large-Cell, Follicular


subject: UNII:YFZ7N482WG

object_name: nonpapillary renal cell carcinoma


subject: UNII:YFZ7N482WG

object_name: clear cell renal carcinoma


subject: UNII:YFZ7N482WG

object_name: renal cell adenocarcinoma


subject: UNII:YFZ7N482WG

object_name: renal cell carcinoma


subject: UNII:YFZ7N482WG

object_name: mantle cell lymphoma


subject: UMLS:C3896768

subject_name: Anti-CD70 Antibody-drug Conjugate SGN-CD70A


subject: UMLS:C3896768


subject: UMLS:C3896768


subject: UMLS:C3896768


subject: UMLS:C3896768


subject: UMLS:C3896768


subject: UMLS:C3896768


subject: GTOPDB:8458

subject_name: otelixizumab

object_name: rheumatoid arthritis


subject: UNII:I5HF2X04PB


subject: UMLS:C2935224


subject: CHEBI:47612

subject_name: Bezafibrate

object_name: inborn mitochondrial metabolism disorder


subject: CHEBI:47612

object_name: mitochondrial disease


subject: UMLS:C1588339

subject_name: CLOZAPINE (FAZACLO)

object_name: Weight Gain


subject: UMLS:C1588339

object_name: Weight Gain, CTCAE


subject: UMLS:C1588339

object_name: Drooling


subject: CHEBI:3766

subject_name: Clozapine


subject: CHEBI:3766


subject: CHEBI:3766


subject: CHEBI:233362

subject_name: Abemaciclib

object_name: neurofibromatosis 1


subject: CHEBI:233362

object_name: neurofibromatosis type 1


subject: UMLS:C5445196

subject_name: Oxaliplatin Liquid Injection

object_name: liver carcinoma


subject: CHEBI:1457

subject_name: Tramiprosate

object_name: Alzheimer disease type 1


subject: DRUGBANK:DB17246


subject: DRUGBANK:DB17246

object_name: Childhood Solid Neoplasm


subject: DRUGBANK:DB17246

object_name: Adult Solid Neoplasm


subject: DRUGBANK:DB17246

object_name: Solid Neoplasm


subject: DRUGBANK:DB17246

object_name: adult hepatocellular carcinoma


subject: DRUGBANK:DB17246

object_name: liver cancer


subject: DRUGBANK:DB17246

object_name: pediatric hepatocellular carcinoma


subject: DRUGBANK:DB17246

object_name: Recurrent Hepatocellular Carcinoma


subject: DRUGBANK:DB17246

object_name: Unresectable Hepatocellular Carcinoma


subject: DRUGBANK:DB17246

object_name: Liver, cancer of, non-resectable


subject: DRUGBANK:DB17246

object_name: liver neoplasm


subject: DRUGBANK:DB17246

object_name: Adult Liver Carcinoma


subject: UNII:7JTT036WGX

subject_name: Glumetinib

object_name: MET Exon 14 Mutation


subject: CHEBI:17154

subject_name: Nicotinamide

object_name: Melasma


subject: CHEBI:26536

subject_name: retinoic acid


subject: CHEBI:28870


subject: CHEBI:6067

subject_name: Isotretinoin


subject: CHEBI:28939

subject_name: Acetylcysteine

object_name: Decreased liver function


subject: UMLS:C0027754

subject_name: Nerve Growth Factors

object_name: Acute Ischemic Stroke


subject: UMLS:C0027754

object_name: Ischemic stroke


subject: MESH:C000631987

object_name: Tinnitus, Subjective


subject: UNII:8Y3RH62XPB

object_name: rheumatoid arthritis


subject: UMLS:C4551943


subject: CHEBI:50742

subject_name: cyproterone

object_name: acne


subject: UNII:7N13IK9LNH

object_name: non-Hodgkin lymphoma


subject: UNII:7N13IK9LNH

object_name: mantle cell lymphoma


subject: DRUGBANK:DB19041

subject_name: Elimusertib


subject: DRUGBANK:DB19041


subject: UMLS:C3541937

subject_name: Azadirachta indica whole extract

object_name: arsenic poisoning chronic


subject: CHEBI:29002


subject: CHEBI:28972

subject_name: (R)-Propylene glycol


subject: CHEBI:16997

subject_name: Propylene glycol


subject: CHEBI:30762

subject_name: salicylate


subject: CHEBI:9008

subject_name: salicylurate


subject: CHEBI:16914

subject_name: Salicylic acid


subject: CHEBI:49662

subject_name: Indomethacin

object_name: triple-negative breast carcinoma


subject: CHEBI:49662

object_name: Triple-Negative Breast Cancer Finding


subject: CHEBI:49662

object_name: breast neoplasm


subject: CHEBI:49662

object_name: male breast carcinoma


subject: UMLS:C0301532

subject_name: Multivitamin preparation


subject: UMLS:C0301532


subject: UMLS:C0301532


subject: UMLS:C0301532


subject: CHEBI:7772

subject_name: omeprazole


subject: CHEBI:7772


subject: CHEBI:7772


subject: CHEBI:7772


subject: CHEBI:77260

subject_name: Omeprazole


subject: CHEBI:77260


subject: CHEBI:77260


subject: GTOPDB:8264

subject_name: fresolimumab

object_name: osteogenesis imperfecta


subject: UNII:375142VBIA


subject: UMLS:C1832030


subject: UNII:66QR34C83N

subject_name: PIXATIMOD

object_name: non-small cell lung carcinoma


subject: UNII:66QR34C83N

object_name: Metastatic Colorectal Carcinoma


subject: UNII:66QR34C83N

object_name: Refractory Melanoma


subject: DRUGBANK:DB19166

subject_name: Pixatimod


subject: DRUGBANK:DB19166


subject: DRUGBANK:DB19166


subject: UMLS:C1527137

subject_name: Recombinant melatonin

object_name: Cell Invasion


subject: CHEBI:16796

subject_name: Melatonin


subject: UNII:NY0COC51FI

subject_name: Tradipitant

object_name: obesity due to melanocortin 4 receptor deficiency


subject: UNII:NY0COC51FI

object_name: obesity


subject: UNII:NY0COC51FI

object_name: Obesity, CTCAE


subject: CHEBI:119915

subject_name: Fentanyl

object_name: Immunotoxicity


subject: CHEBI:119915

object_name: Inert Gas Narcosis


subject: CHEBI:9130

subject_name: Sevoflurane


subject: CHEBI:9130


subject: CHEBI:3215

subject_name: Bupivacaine

object_name: Fracture of tibia and fibula


subject: CHEBI:3215

object_name: Fracture dislocation of ankle joint


subject: CHEBI:3215

object_name: Fractured lower leg


subject: CHEBI:170007

subject_name: Nirmatrelvir

object_name: Chronic post-COVID-19 syndrome


subject: CHEBI:170007

object_name: Post-COVID-19 syndrome


subject: CHEBI:170007

object_name: Post-COVID syndrome


subject: CHEBI:170007

object_name: Irritable heart


subject: CHEBI:170007

object_name: Postinfection inflammation


subject: CHEBI:170007

object_name: post-infectious disorder


subject: CHEBI:45409

subject_name: Ritonavir


subject: CHEBI:45409

object_name: long COVID-19


subject: CHEBI:45409


subject: CHEBI:45409


subject: CHEBI:45409


subject: CHEBI:45409


subject: CHEBI:45409


subject: UNII:73B0K5S26A

subject_name: Belimumab

object_name: nephrotic syndrome


subject: UNII:73B0K5S26A

object_name: Nephrotic Syndrome, CTCAE


subject: CHEBI:135622

subject_name: Besifloxacin

object_name: Bacterial keratitis


subject: PUBCHEM.COMPOUND:15556483

subject_name: METHIONINE C 11

object_name: Childhood Craniopharyngioma


subject: PUBCHEM.COMPOUND:15556483

object_name: craniopharyngioma


subject: PUBCHEM.COMPOUND:15556483

object_name: Adult Craniopharyngioma


subject: UNII:ED857BWP29

subject_name: Methionine C-11


subject: UNII:ED857BWP29


subject: UNII:ED857BWP29


subject: UMLS:C0252667


subject: UMLS:C0252667


subject: UMLS:C0252667


subject: CHEBI:49140


subject: CHEBI:49140


subject: CHEBI:49140


subject: PUBCHEM.COMPOUND:3232583


subject: PUBCHEM.COMPOUND:3232583


subject: PUBCHEM.COMPOUND:3232583


subject: PUBCHEM.COMPOUND:451195

subject_name: Fluorodeoxyglucose F 18


subject: PUBCHEM.COMPOUND:451195


subject: PUBCHEM.COMPOUND:451195


subject: CHEBI:49134


subject: CHEBI:49134


subject: CHEBI:49134


subject: CHEBI:31617

subject_name: fludeoxyglucose (18F)


subject: CHEBI:31617


subject: CHEBI:31617


subject: CHEBI:465284

subject_name: Ganciclovir

object_name: viral conjunctivitis


subject: CHEBI:465284

object_name: adenoviridae infectious disease


subject: UMLS:C4732965

subject_name: TS-One

object_name: cancer


subject: UMLS:C4732965

object_name: neoplasm


subject: CHEBI:7640

subject_name: Nortriptyline

object_name: atopic eczema


subject: CHEBI:6538

subject_name: Loratadine


subject: CHEBI:144903

subject_name: Pro-Arg-Pro

object_name: endometrial disorder


subject: CHEBI:61848


subject: PR:000013192


subject: UniProtKB:P05142

subject_name: PRH1_MOUSE Proline-rich protein HaeIII subfamily 1 (sprot)


subject: PR:000013551


subject: PR:000003551

subject_name: ATP-binding cassette sub-family B member 6


subject: UniProtKB:P67986

subject_name: PRIO_CEREN Major prion protein (sprot)


subject: PR:000001886

subject_name: major prion protein


subject: PR:000030465

subject_name: C4b-binding protein alpha chain


subject: PR:000013555

subject_name: proline-rich protein 2


subject: UniProtKB:P05143

subject_name: PRP2_MOUSE Proline-rich protein 2 (sprot)


subject: PR:000032963

subject_name: proline-rich protein HaeIII subfamily 1


subject: UNII:N5UK68MGDZ

subject_name: Apremilast

object_name: psoriasis-related juvenile idiopathic arthritis


subject: CHEBI:167574

subject_name: Semaglutide

object_name: HIV-1 infection


subject: CHEBI:93775

subject_name: Amethopterin

object_name: ocular sarcoidosis


subject: CHEBI:93775

object_name: Macular Edema


subject: CHEBI:50681


subject: CHEBI:50681


subject: CHEBI:44185

subject_name: Methotrexate


subject: CHEBI:44185


subject: PUBCHEM.COMPOUND:1805

subject_name: Azacytidine, 5-

object_name: mantle cell lymphoma


subject: PUBCHEM.COMPOUND:1805

object_name: B-cell non-Hodgkin lymphoma


subject: CHEBI:2038

subject_name: Azacitidine


subject: CHEBI:2038


subject: UMLS:C5447522

subject_name: Myeloid Cell Leukemia 1 Inhibitor PRT1419

object_name: juvenile myelomonocytic leukemia


subject: UMLS:C5447522

object_name: chronic myelomonocytic leukemia


subject: UMLS:C5447522

object_name: B-cell chronic lymphocytic leukemia


subject: UMLS:C5447522


subject: UMLS:C5447522


subject: UMLS:C5447522

object_name: B-cell neoplasm


subject: UMLS:C5447522

object_name: myeloproliferative neoplasm


subject: UMLS:C5447522

object_name: Malignant myeloproliferative neoplasm


subject: UMLS:C5447522

object_name: marginal zone lymphoma


subject: UMLS:C5447522

object_name: MALT lymphoma


subject: UMLS:C5447522

object_name: follicular lymphoma


subject: CHEBI:132082

subject_name: Entinostat


subject: CHEBI:132922

object_name: Atopic rhinitis


subject: CHEBI:132922

object_name: Allergic Rhinitis, CTCAE


subject: CHEBI:43415

subject_name: Dexibuprofen


subject: CHEBI:43415


subject: CHEBI:5855

subject_name: Ibuprofen


subject: CHEBI:5855


subject: CHEBI:8228

subject_name: Pioglitazone

object_name: castration-resistant prostate carcinoma


subject: CHEBI:38545

subject_name: Rosuvastatin


subject: DRUGBANK:DB18487

object_name: acute lymphoblastic leukemia


subject: DRUGBANK:DB18487

object_name: lymphoma


subject: UNII:QQA9MLH692

subject_name: Tafasitamab

object_name: Adult Non-Hodgkin Lymphoma


subject: UNII:QQA9MLH692

object_name: Childhood Non-Hodgkin Lymphoma


subject: UNII:6OB452MC0E

subject_name: Triciribine phosphate monohydrate

object_name: cancer


subject: UNII:6OB452MC0E

object_name: neoplasm


subject: CHEBI:45783

subject_name: Imatinib

object_name: plexiform neurofibroma


subject: CHEBI:193615

object_name: rectal carcinoma


subject: CHEBI:193615

object_name: rectal cancer


subject: CHEBI:193615

object_name: Childhood Rectal Carcinoma


subject: CHEBI:193615

object_name: colon carcinoma


subject: CHEBI:193615

object_name: colon cancer


subject: CHEBI:60761

subject_name: Floxuridine


subject: CHEBI:60761


subject: CHEBI:60761


subject: CHEBI:60761


subject: CHEBI:60761


subject: CHEBI:86327

subject_name: antifungal drug

object_name: corneal infection


subject: CHEBI:86327

object_name: Keratitis caused by infection


subject: CHEBI:49040

subject_name: Ezetimibe

object_name: Chronic acalculous cholecystitis


subject: CHEBI:4466

subject_name: Dexmedetomidine

object_name: scoliosis, isolated, susceptibility to, 1


subject: UNII:7N8K34P2XH

subject_name: Detomidine


subject: UMLS:C5239410

subject_name: CBD Oil

object_name: cannabis abuse


subject: UMLS:C5239410

object_name: opioid use


subject: PUBCHEM.COMPOUND:596

subject_name: Cylocide

object_name: prostate carcinoma


subject: PUBCHEM.COMPOUND:596

object_name: prostate cancer


subject: CHEBI:28680

subject_name: Cytarabine


subject: CHEBI:28680


subject: CHEMBL.COMPOUND:CHEMBL5095379

subject_name: ZIFIBANCIMIG

object_name: macular degeneration


subject: CHEMBL.COMPOUND:CHEMBL5095379

object_name: age-related macular degeneration


subject: CHEMBL.COMPOUND:CHEMBL5095379

object_name: retinitis pigmentosa 30


subject: UMLS:C5783647

subject_name: Zifibancimig


subject: UMLS:C5783647


subject: UMLS:C5783647


subject: CHEBI:49603

subject_name: Lapatinib

object_name: Advanced cancer


subject: CHEBI:83161

subject_name: St. John's wort extract

object_name: atypical depressive disorder


subject: CHEMBL.COMPOUND:CHEMBL2108102

subject_name: ST. JOHN'S WORT


subject: UMLS:C4745355

object_name: Oral Mucositis


subject: UMLS:C4745355

object_name: stomatitis


subject: UMLS:C4745355

object_name: oral mucositis


subject: UNII:46VZA7RX2B

subject_name: MECLOCYCLINE SULFOSALICYLATE


subject: UNII:46VZA7RX2B


subject: UNII:46VZA7RX2B


subject: PUBCHEM.COMPOUND:54684337

subject_name: meclocycline


subject: PUBCHEM.COMPOUND:54684337


subject: PUBCHEM.COMPOUND:54684337


subject: CHEBI:135772

subject_name: Meclocycline


subject: CHEBI:135772


subject: CHEBI:135772


subject: CHEBI:228380

subject_name: ANH

object_name: ovarian cancer


subject: CHEBI:228380

object_name: ovarian neoplasm


subject: CHEBI:228380

object_name: ovarian carcinoma


subject: CHEBI:228380

object_name: Stage IV Ovarian Cancer AJCC v6 and v7


subject: CHEBI:228380

object_name: Ovarian cancer stage IV


subject: CHEBI:228380

object_name: malignant neoplasm of ovary stage IV


subject: CHEBI:228380

object_name: malignant neoplasm of ovary stage IIIc


subject: CHEBI:228380

object_name: Stage IIIC Ovarian Cancer


subject: CHEBI:228380

object_name: malignant epithelial tumor of ovary


subject: CHEBI:228380

object_name: Stage IV Fallopian Tube Cancer AJCC v6 and v7


subject: CHEBI:228380

object_name: Malignant neoplasm of fallopian tube metastatic


subject: CHEBI:228380

object_name: Stage IIIC Fallopian Tube Cancer AJCC v7


subject: CHEBI:228380

object_name: peritoneum cancer


subject: CHEBI:228380

object_name: fallopian tube carcinoma


subject: CHEBI:228380

object_name: fallopian tube cancer


subject: CHEBI:228380

object_name: Carcinoma of peritoneum


subject: CHEBI:228380

object_name: peritoneal carcinoma


subject: UNII:609AWV0US2

object_name: Chronic obstructive pulmonary disease of horses


subject: UNII:609AWV0US2

object_name: COPD, severe early onset


subject: UNII:609AWV0US2

object_name: chronic obstructive pulmonary disease


subject: CHEMBL.COMPOUND:CHEMBL4297701


subject: CHEMBL.COMPOUND:CHEMBL4297701


subject: CHEMBL.COMPOUND:CHEMBL4297701


subject: UMLS:C4745025


subject: UMLS:C4745025


subject: UMLS:C4745025


subject: MESH:D000485

subject_name: Allergens

object_name: Inflammation


subject: MESH:D000485

object_name: Increased reactive oxygen species production


subject: MESH:D000485

object_name: food toxicity


subject: CHEBI:4305

subject_name: dacarbazine

object_name: Lugano Classification Stage IV Hodgkin Lymphoma AJCC v8


subject: CHEBI:4305

object_name: Lugano Classification Stage III Hodgkin Lymphoma AJCC v8


subject: CHEBI:64816


subject: CHEBI:64816


subject: CHEBI:91872


subject: CHEBI:91872


subject: CHEBI:28748

subject_name: Doxorubicin


subject: CHEBI:28748


subject: CHEBI:231614

subject_name: Nivolumab

object_name: Advanced Hodgkin Lymphoma


subject: CHEBI:231614


subject: CHEBI:231614


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: CHEBI:27375

subject_name: Vinblastine


subject: CHEBI:27375


subject: PUBCHEM.COMPOUND:156539584

object_name: neoplasm of mature B-cells


subject: PUBCHEM.COMPOUND:156539584

object_name: diffuse large B-cell lymphoma germinal center B-cell type


subject: PUBCHEM.COMPOUND:156539584

object_name: high grade B-cell lymphoma


subject: PUBCHEM.COMPOUND:156539584

object_name: ALK-positive large B-cell lymphoma


subject: PUBCHEM.COMPOUND:156539584

object_name: Primary cutaneous diffuse large cell B-cell lymphoma


subject: PUBCHEM.COMPOUND:156539584

object_name: Primary Cutaneous Diffuse Large B-Cell Lymphoma, Other


subject: PUBCHEM.COMPOUND:156539584

object_name: primary cutaneous follicle center lymphoma


subject: PUBCHEM.COMPOUND:156539584

object_name: primary mediastinal large B-cell lymphoma


subject: PUBCHEM.COMPOUND:156539584

object_name: lymphoplasmacytic lymphoma


subject: PUBCHEM.COMPOUND:156539584

object_name: Waldenstrom macroglobulinemia


subject: PUBCHEM.COMPOUND:156539584

object_name: Pediatric follicular lymphoma


subject: PUBCHEM.COMPOUND:156539584

object_name: Duodenal-type follicular lymphoma


subject: PUBCHEM.COMPOUND:156539584

object_name: T-cell/histiocyte rich large B cell lymphoma


subject: PUBCHEM.COMPOUND:156539584

object_name: nodal marginal zone B-cell lymphoma


subject: PUBCHEM.COMPOUND:156539584

object_name: MALT lymphoma


subject: PUBCHEM.COMPOUND:156539584

object_name: splenic marginal zone lymphoma


subject: PUBCHEM.COMPOUND:156539584

object_name: plasmablastic lymphoma


subject: PUBCHEM.COMPOUND:156539584

object_name: large-cell immunoblastic lymphoma


subject: PUBCHEM.COMPOUND:156539584

object_name: B-cell chronic lymphocytic leukemia


subject: PUBCHEM.COMPOUND:156539584

object_name: mantle cell lymphoma


subject: PUBCHEM.COMPOUND:156539584

object_name: primary effusion lymphoma


subject: PUBCHEM.COMPOUND:156539584

object_name: IRF4 Gene Rearrangement


subject: PUBCHEM.COMPOUND:156539584

object_name: Epstein-Barr virus-positive diffuse large B-cell lymphoma of the elderly


subject: PUBCHEM.COMPOUND:156539584

object_name: HHV8-Positive Diffuse Large B-Cell Lymphoma, Not Otherwise Specified


subject: PUBCHEM.COMPOUND:156539584

object_name: non-Hodgkin lymphoma


subject: PUBCHEM.COMPOUND:156539584

object_name: follicular lymphoma


subject: PUBCHEM.COMPOUND:156539584

object_name: Burkitt lymphoma


subject: PUBCHEM.COMPOUND:156539584

object_name: Childhood Burkitt Lymphoma


subject: PUBCHEM.COMPOUND:156539584

object_name: Adult Burkitt Lymphoma


subject: PUBCHEM.COMPOUND:156539584

object_name: diffuse large B-cell lymphoma


subject: UMLS:C5784738

subject_name: MALT1 Inhibitor SGR-1505

object_name: neoplasm of mature B-cells


subject: UMLS:C5784738

object_name: diffuse large B-cell lymphoma germinal center B-cell type


subject: UMLS:C5784738

object_name: high grade B-cell lymphoma


subject: UMLS:C5784738

object_name: ALK-positive large B-cell lymphoma


subject: UMLS:C5784738

object_name: Primary cutaneous diffuse large cell B-cell lymphoma


subject: UMLS:C5784738

object_name: Primary Cutaneous Diffuse Large B-Cell Lymphoma, Other


subject: UMLS:C5784738

object_name: primary cutaneous follicle center lymphoma


subject: UMLS:C5784738

object_name: primary mediastinal large B-cell lymphoma


subject: UMLS:C5784738

object_name: lymphoplasmacytic lymphoma


subject: UMLS:C5784738

object_name: Waldenstrom macroglobulinemia


subject: UMLS:C5784738

object_name: Pediatric follicular lymphoma


subject: UMLS:C5784738

object_name: Duodenal-type follicular lymphoma


subject: UMLS:C5784738

object_name: T-cell/histiocyte rich large B cell lymphoma


subject: UMLS:C5784738

object_name: nodal marginal zone B-cell lymphoma


subject: UMLS:C5784738

object_name: MALT lymphoma


subject: UMLS:C5784738

object_name: splenic marginal zone lymphoma


subject: UMLS:C5784738

object_name: plasmablastic lymphoma


subject: UMLS:C5784738

object_name: large-cell immunoblastic lymphoma


subject: UMLS:C5784738

object_name: B-cell chronic lymphocytic leukemia


subject: UMLS:C5784738

object_name: mantle cell lymphoma


subject: UMLS:C5784738

object_name: primary effusion lymphoma


subject: UMLS:C5784738

object_name: IRF4 Gene Rearrangement


subject: UMLS:C5784738

object_name: Epstein-Barr virus-positive diffuse large B-cell lymphoma of the elderly


subject: UMLS:C5784738

object_name: HHV8-Positive Diffuse Large B-Cell Lymphoma, Not Otherwise Specified


subject: UMLS:C5784738

object_name: non-Hodgkin lymphoma


subject: UMLS:C5784738

object_name: follicular lymphoma


subject: UMLS:C5784738

object_name: Burkitt lymphoma


subject: UMLS:C5784738

object_name: Childhood Burkitt Lymphoma


subject: UMLS:C5784738

object_name: Adult Burkitt Lymphoma


subject: UMLS:C5784738

object_name: diffuse large B-cell lymphoma


subject: UNII:9A59ESA73N

object_name: neoplasm of mature B-cells


subject: UNII:9A59ESA73N

object_name: diffuse large B-cell lymphoma germinal center B-cell type


subject: UNII:9A59ESA73N

object_name: high grade B-cell lymphoma


subject: UNII:9A59ESA73N

object_name: ALK-positive large B-cell lymphoma


subject: UNII:9A59ESA73N

object_name: Primary cutaneous diffuse large cell B-cell lymphoma


subject: UNII:9A59ESA73N

object_name: Primary Cutaneous Diffuse Large B-Cell Lymphoma, Other


subject: UNII:9A59ESA73N

object_name: primary cutaneous follicle center lymphoma


subject: UNII:9A59ESA73N

object_name: primary mediastinal large B-cell lymphoma


subject: UNII:9A59ESA73N

object_name: lymphoplasmacytic lymphoma


subject: UNII:9A59ESA73N

object_name: Waldenstrom macroglobulinemia


subject: UNII:9A59ESA73N

object_name: Pediatric follicular lymphoma


subject: UNII:9A59ESA73N

object_name: Duodenal-type follicular lymphoma


subject: UNII:9A59ESA73N

object_name: T-cell/histiocyte rich large B cell lymphoma


subject: UNII:9A59ESA73N

object_name: nodal marginal zone B-cell lymphoma


subject: UNII:9A59ESA73N

object_name: MALT lymphoma


subject: UNII:9A59ESA73N

object_name: splenic marginal zone lymphoma


subject: UNII:9A59ESA73N

object_name: plasmablastic lymphoma


subject: UNII:9A59ESA73N

object_name: large-cell immunoblastic lymphoma


subject: UNII:9A59ESA73N

object_name: B-cell chronic lymphocytic leukemia


subject: UNII:9A59ESA73N

object_name: mantle cell lymphoma


subject: UNII:9A59ESA73N

object_name: primary effusion lymphoma


subject: UNII:9A59ESA73N

object_name: IRF4 Gene Rearrangement


subject: UNII:9A59ESA73N

object_name: Epstein-Barr virus-positive diffuse large B-cell lymphoma of the elderly


subject: UNII:9A59ESA73N

object_name: HHV8-Positive Diffuse Large B-Cell Lymphoma, Not Otherwise Specified


subject: UNII:9A59ESA73N

object_name: non-Hodgkin lymphoma


subject: UNII:9A59ESA73N

object_name: follicular lymphoma


subject: UNII:9A59ESA73N

object_name: Burkitt lymphoma


subject: UNII:9A59ESA73N

object_name: Childhood Burkitt Lymphoma


subject: UNII:9A59ESA73N

object_name: Adult Burkitt Lymphoma


subject: UNII:9A59ESA73N

object_name: diffuse large B-cell lymphoma


subject: UMLS:C5237347

subject_name: Anti-BCMA/Anti-CD3 Bispecific Antibody REGN5459

object_name: Plasma cell myeloma refractory


subject: CHEMBL.COMPOUND:CHEMBL4297877

subject_name: BALSTILIMAB

object_name: Metastatic Gastroesophageal Junction Adenocarcinoma


subject: CHEMBL.COMPOUND:CHEMBL4297877

object_name: Unresectable Gastroesophageal Junction Adenocarcinoma


subject: CHEMBL.COMPOUND:CHEMBL4297877

object_name: Esophageal adenocarcinoma stage IV


subject: CHEMBL.COMPOUND:CHEMBL4297877

object_name: Unresectable Esophageal Adenocarcinoma


subject: CHEMBL.COMPOUND:CHEMBL4297877

object_name: Metastatic gastric adenocarcinoma


subject: CHEMBL.COMPOUND:CHEMBL4297877

object_name: Unresectable Gastric Adenocarcinoma


subject: CHEMBL.COMPOUND:CHEMBL4297877

object_name: Metastatic Esophageal Carcinoma


subject: CHEMBL.COMPOUND:CHEMBL4297877

object_name: stage IV esophageal cancer


subject: CHEMBL.COMPOUND:CHEMBL4297877

object_name: Unresectable Esophageal Carcinoma


subject: CHEMBL.COMPOUND:CHEMBL4297877

object_name: Advanced Gastric Adenocarcinoma


subject: CHEMBL.COMPOUND:CHEMBL4297877

object_name: Metastatic Gastric Carcinoma


subject: CHEMBL.COMPOUND:CHEMBL4297877

object_name: Malignant neoplasm of stomach stage IV


subject: CHEMBL.COMPOUND:CHEMBL4297877

object_name: Unresectable Gastric Carcinoma


subject: UMLS:C4526708


subject: UMLS:C4526708


subject: UMLS:C4526708


subject: UMLS:C4526708


subject: UMLS:C4526708


subject: UMLS:C4526708


subject: UMLS:C4526708


subject: UMLS:C4526708


subject: UMLS:C4526708


subject: UMLS:C4526708


subject: UMLS:C4526708


subject: UMLS:C4526708


subject: UMLS:C4526708


subject: CHEMBL.COMPOUND:CHEMBL4650435

subject_name: BOTENSILIMAB


subject: CHEMBL.COMPOUND:CHEMBL4650435


subject: CHEMBL.COMPOUND:CHEMBL4650435


subject: CHEMBL.COMPOUND:CHEMBL4650435


subject: CHEMBL.COMPOUND:CHEMBL4650435


subject: CHEMBL.COMPOUND:CHEMBL4650435


subject: CHEMBL.COMPOUND:CHEMBL4650435


subject: CHEMBL.COMPOUND:CHEMBL4650435


subject: CHEMBL.COMPOUND:CHEMBL4650435


subject: CHEMBL.COMPOUND:CHEMBL4650435


subject: CHEMBL.COMPOUND:CHEMBL4650435


subject: CHEMBL.COMPOUND:CHEMBL4650435


subject: CHEMBL.COMPOUND:CHEMBL4650435


subject: UMLS:C4764272

subject_name: Botensilimab


subject: UMLS:C4764272


subject: UMLS:C4764272


subject: UMLS:C4764272


subject: UMLS:C4764272


subject: UMLS:C4764272


subject: UMLS:C4764272


subject: UMLS:C4764272


subject: UMLS:C4764272


subject: UMLS:C4764272


subject: UMLS:C4764272


subject: UMLS:C4764272


subject: UMLS:C4764272


subject: CHEBI:45863

subject_name: Paclitaxel


subject: CHEBI:45863


subject: CHEBI:45863


subject: CHEBI:45863


subject: CHEBI:45863


subject: UNII:D99YVK4L0X

subject_name: Ramucirumab


subject: UNII:D99YVK4L0X


subject: UNII:D99YVK4L0X


subject: UNII:D99YVK4L0X


subject: UNII:D99YVK4L0X


subject: UMLS:C1721684

subject_name: lexatumumab


subject: UMLS:C1721684


subject: UMLS:C1721684


subject: UMLS:C1721684


subject: UMLS:C1721684


subject: UMLS:C1251704

subject_name: Lidocaine Patch

object_name: urgency urinary incontinence


subject: UMLS:C1251704

object_name: Bowel incontinence


subject: UMLS:C1251704

object_name: Fecal Incontinence, CTCAE


subject: UMLS:C1251704

object_name: Urinary Urgency


subject: GTOPDB:13649

subject_name: zenocutuzumab

object_name: NRG1 Gene Fusion Positive


subject: CHEMBL.COMPOUND:CHEMBL4298025

subject_name: ZENOCUTUZUMAB


subject: CHEBI:137359

object_name: Low muscle mass


subject: CHEBI:137359

object_name: type 2 diabetes mellitus


subject: CHEBI:137359

object_name: Diabetes


subject: CHEBI:137359

object_name: diabetes mellitus


subject: CHEBI:37084

subject_name: beta-Hydroxyisovaleric acid


subject: CHEBI:37084


subject: CHEBI:37084


subject: CHEMBL.COMPOUND:CHEMBL4525124

subject_name: HMB


subject: CHEMBL.COMPOUND:CHEMBL4525124


subject: CHEMBL.COMPOUND:CHEMBL4525124


subject: CHEMBL.COMPOUND:CHEMBL4525124


subject: CHEBI:70746

subject_name: Dabigatran etexilate

object_name: intracerebral hemorrhage


subject: CHEBI:70752

subject_name: Dabigatran


subject: CHEBI:68579

subject_name: Rivaroxaban


subject: PUBCHEM.COMPOUND:11635624

subject_name: Edoxaban


subject: CHEMBL.COMPOUND:CHEMBL2109103

subject_name: BERTILIMUMAB

object_name: Ulcerative colitis, active moderate


subject: CHEMBL.COMPOUND:CHEMBL2109103

object_name: Ulcerative colitis, active severe


subject: UMLS:C5238160

subject_name: Bertilimumab


subject: UMLS:C5238160


subject: UMLS:C1706653

subject_name: Aminoflavone Prodrug AFP464

object_name: breast neoplasm


subject: UNII:CEGM9YBNGD

subject_name: Selpercatinib

object_name: Hepatic impairment


subject: CHEBI:187893

subject_name: Baclofen

object_name: Adherence To Medication Regime


subject: CHEBI:187893

object_name: Drug toxicity


subject: PUBCHEM.COMPOUND:3962

object_name: Melanoma in situ


subject: PUBCHEM.COMPOUND:3962

object_name: Stage 0 Cutaneous Melanoma AJCC v6 and v7


subject: PUBCHEM.COMPOUND:3962

object_name: stage II melanoma


subject: PUBCHEM.COMPOUND:3962

object_name: Stage II Cutaneous Melanoma AJCC v6 and v7


subject: PUBCHEM.COMPOUND:3962

object_name: Stage I Cutaneous Melanoma AJCC v6


subject: PUBCHEM.COMPOUND:3962

object_name: precancerous condition


subject: CHEBI:40303

subject_name: Lovastatin


subject: CHEBI:40303


subject: CHEBI:40303


subject: CHEBI:40303


subject: CHEBI:40303


subject: CHEBI:40303


subject: CHEBI:88316

subject_name: Nefopam

object_name: Primary malignant neoplasm of breast


subject: UMLS:C3714633

subject_name: Penicillamine Drug Class

object_name: Neck Carcinoma


subject: UMLS:C3714633

object_name: head and neck neoplasm


subject: UMLS:C3714633

object_name: head and neck cancer


subject: UMLS:C3714633

object_name: Recurrent Malignant Neoplasm


subject: UMLS:C3714633

object_name: Recurrent Carcinoma


subject: CHEBI:7959

subject_name: Penicillamine


subject: CHEBI:7959


subject: CHEBI:7959


subject: CHEBI:7959


subject: CHEBI:7959


subject: UMLS:C0025536

subject_name: Metalcaptase


subject: UMLS:C0025536


subject: UMLS:C0025536


subject: UMLS:C0025536


subject: UMLS:C0025536


subject: CHEBI:50853

subject_name: quantum dot

object_name: liver carcinoma


subject: UMLS:C4289970

subject_name: Anti-PD1 Monoclonal Antibody

object_name: rectal neoplasm


subject: UMLS:C0919079

subject_name: TEMOZOLOMIDE, ORAL, 5 MG ADMINISTERED

object_name: Metastatic non-small cell lung cancer


subject: UMLS:C0919079

object_name: Non-small cell lung cancer recurrent


subject: CHEBI:72564

subject_name: Temozolomide


subject: CHEBI:72564


subject: UMLS:C2830069

subject_name: Smoothened Antagonist LDE225

object_name: Pancreas carcinoma resectable


subject: CHEBI:90863

subject_name: Sonidegib


subject: PUBCHEM.COMPOUND:633097

subject_name: Kenalog

object_name: CAPN5-related vitreoretinopathy


subject: PUBCHEM.COMPOUND:633097

object_name: proliferative vitreoretinopathy


subject: UNII:WTT295HSY5

subject_name: Dulaglutide

object_name: chronic kidney disease


subject: UNII:WTT295HSY5

object_name: Chronic Kidney Disease, CTCAE


subject: UMLS:C2976495


subject: UMLS:C2976495


subject: PR:000015526

subject_name: transcription factor Spi-C

object_name: Intrabony periodontal defect


subject: UMLS:C0033374

subject_name: Prolactin-Releasing Hormone


subject: UNII:4MD2J2T8SJ

subject_name: brexucabtagene autoleucel

object_name: acute lymphoblastic leukemia


subject: DRUGBANK:DB06184

object_name: Mammary Carcinoma, Human


subject: UMLS:C2698850

subject_name: Pomegranate-Extract Pill

object_name: Stage IIA Prostate Cancer AJCC v7


subject: UMLS:C2698850

object_name: Stage I Prostate Cancer AJCC v7


subject: UMLS:C2698850

object_name: Stage II Prostate Cancer AJCC v7


subject: UMLS:C2698850

object_name: Stage IIB Prostate Cancer AJCC v7


subject: UMLS:C2698850

object_name: PSA Level Less than or Equal to Fifteen


subject: UMLS:C2698850

object_name: PSA Level Less than Ten


subject: UNII:4F4X42SYQ6

subject_name: Rituximab

object_name: Off-Label Use


subject: UNII:4F4X42SYQ6

object_name: Off-Label Use (medical device)


subject: UMLS:C0295415

subject_name: rituximab


subject: UMLS:C0295415


subject: CHEBI:9168

subject_name: Sirolimus

object_name: cytomegalovirus infection


subject: UMLS:C2346882

subject_name: Autologous Dendritic Cell-Adenovirus CCL21 Vaccine

object_name: Stage IV Lung Cancer AJCC v8


subject: UMLS:C2346882

object_name: non-small cell lung carcinoma


subject: UMLS:C2346882

object_name: Stage IVA Lung Cancer AJCC v8


subject: UMLS:C2346882

object_name: Stage IVB Lung Cancer AJCC v8


subject: DRUGBANK:DB05918

object_name: glioma


subject: DRUGBANK:DB05918

object_name: malignant glioma


subject: DRUGBANK:DB05918

object_name: Grade III Childhood Astrocytoma


subject: DRUGBANK:DB05918

object_name: Adult Anaplastic Astrocytoma


subject: DRUGBANK:DB05918

object_name: anaplastic astrocytoma


subject: DRUGBANK:DB05918

object_name: glioblastoma


subject: DRUGBANK:DB05918

object_name: Brain Stem Glioblastoma


subject: DRUGBANK:DB05918

object_name: glioma susceptibility 1


subject: UNII:L63605PZ70

subject_name: TALAPORFIN SODIUM


subject: UNII:L63605PZ70


subject: UNII:L63605PZ70


subject: UNII:L63605PZ70


subject: UNII:L63605PZ70


subject: UNII:L63605PZ70


subject: UNII:L63605PZ70


subject: UNII:L63605PZ70


subject: UMLS:C1312955

subject_name: talaporfin sodium


subject: UMLS:C1312955


subject: UMLS:C1312955


subject: UMLS:C1312955


subject: UMLS:C1312955


subject: UMLS:C1312955


subject: UMLS:C1312955


subject: UMLS:C1312955


subject: CHEBI:135875

subject_name: Talaporfin


subject: CHEBI:135875


subject: CHEBI:135875


subject: CHEBI:135875


subject: CHEBI:135875


subject: CHEBI:135875


subject: CHEBI:135875


subject: CHEBI:135875


subject: CHEBI:136037

subject_name: Corticorelin

object_name: cocaine dependence


subject: CHEBI:136037

object_name: cocaine abuse


subject: CHEBI:136037

object_name: substance-related disorder


subject: PR:000005867

subject_name: corticoliberin


subject: PR:000005867


subject: PR:000005867


subject: UNII:15C2VL427D

subject_name: Aflibercept

object_name: Clinically significant macular edema


subject: UMLS:C5979813

object_name: Hepatic impairment


subject: UNII:I7MVZ8HDNU

subject_name: Remibrutinib


subject: CHEBI:39548

subject_name: Atorvastatin

object_name: Well adult


subject: UMLS:C0717761

subject_name: ethinyl estradiol / levonorgestrel


subject: UMLS:C2929264

subject_name: estradiol / ethinyl estradiol / levonorgestrel


subject: CHEBI:6931

subject_name: Midazolam


subject: CHEBI:231951


subject: GTOPDB:13914

subject_name: sapablursen

object_name: beta thalassemia


subject: GTOPDB:13914

object_name: beta-thalassemia intermedia


subject: DRUGBANK:DB18608

subject_name: Sapablursen


subject: DRUGBANK:DB18608


subject: UMLS:C3658170

object_name: vulvodynia


subject: UNII:N5UK68MGDZ

subject_name: Apremilast


subject: CHEBI:26710

subject_name: Sodium chloride

object_name: Anaesthesia intubation complication


subject: MESH:C000628612

object_name: prostate carcinoma


subject: MESH:C000628612

object_name: prostate cancer


subject: PUBCHEM.COMPOUND:129319307

subject_name: Fuzeon

object_name: HIV infection


subject: PUBCHEM.COMPOUND:129319307

object_name: AIDS


subject: CHEBI:27732

subject_name: Caffeine

object_name: vestibular disorder


subject: CHEBI:27732

object_name: dizziness


subject: CHEBI:27732

object_name: Vertigo as late effect of cerebrovascular disease


subject: CHEBI:27732

object_name: Vertigo, CTCAE


subject: CHEBI:31709

subject_name: Iohexol

object_name: bacterial infectious disease


subject: CHEBI:201431

subject_name: Cyclosporin H

object_name: chronic granulomatous disease


subject: CHEBI:4031

subject_name: Cyclosporine


subject: CHEBI:40629

object_name: glioblastoma


subject: CHEBI:40629

object_name: Brain Stem Glioblastoma


subject: CHEBI:40629

object_name: glioma susceptibility 1


subject: UMLS:C3272772


subject: UMLS:C3272772

object_name: Childhood Glioblastoma


subject: UMLS:C3272772

object_name: adult glioblastoma


subject: UMLS:C0947603

subject_name: FUDR brand of floxuridine

object_name: Small Duct Intrahepatic Cholangiocarcinoma


subject: PUBCHEM.COMPOUND:43805

subject_name: Oxaliplatin


subject: UMLS:C1314429

subject_name: INJECTION, OXALIPLATIN, 0.5 MG ADMINISTERED


subject: CHEBI:46195

subject_name: Acetaminophen

object_name: Pharyngitis, CTCAE


subject: CHEBI:34967

subject_name: Rimonabant

object_name: schizophrenia